Tj_的个人主页 - 老虎社区

Tj_

暂无个人介绍

IP属地：未知

363关注

15粉丝

0主题

0勋章

2021-12-07

👍

60 Biggest Movers From Yesterday

2021-11-26

😬😬

盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮

2021-11-17

🤑🤑

抱歉，原内容已删除

2021-11-04

Earn & redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&Page=Me&lang=en_US&skin=1&platform=ios&invite=OX9U7S&share=WhatsAPP#/

2021-11-02

okay

Pfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021

2021-10-09

wow

抱歉，原内容已删除

2021-10-09

okay

NVIDIA acquires formal verification firm Oski Technology

2021-10-09

okay

NVIDIA acquires formal verification firm Oski Technology

2021-09-24

okay

EU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data

2021-09-16

great

抱歉，原内容已删除

2021-09-15

okay

Apple shares rose 0.4% in premarket trading

2021-09-09

woww

抱歉，原内容已删除

2021-08-29

Hmm🤔

抱歉，原内容已删除

2021-08-18

Woww

抱歉，原内容已删除

2021-08-15

Nice!

These 10 Standout Stocks Could Be the Next Amazon

2021-08-13

great

抱歉，原内容已删除

2021-08-09

Nice

抱歉，原内容已删除

2021-08-09

👍

抱歉，原内容已删除

2021-08-08

Great

抱歉，原内容已删除

2021-08-05

nice

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4088479336191950","uuid":"4088479336191950","gmtCreate":1625997491951,"gmtModify":1625997491951,"name":"Tj_","pinyin":"tjtj","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":15,"headSize":363,"tweetSize":28,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":606667471,"gmtCreate":1638873538560,"gmtModify":1638873668908,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606667471","repostId":"1149974752","repostType":4,"repost":{"id":"1149974752","kind":"news","pubTimestamp":1638873109,"share":"https://www.laohu8.com/m/news/1149974752?lang=&edition=full","pubTime":"2021-12-07 18:31","market":"us","language":"en","title":"60 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1149974752","media":"Benzinga","summary":"Gainers\n\nInsignia Systems, Inc. shares jumped 200.4% to close at $15.05 on Monday after the company ","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Insignia Systems, Inc.</b>&nbsp;shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.</li>\n <li><b>Del Taco Restaurants, Inc.</b>&nbsp;shares climbed 66.1% to close at $12.51 on Monday.</li>\n <li><b>Jack In The Box Inc</b>&nbsp;agreed to acquire Del Taco Restaurants for $12.51 per share in cash in a deal valued at about $575 million.</li>\n <li><b>Cumberland Pharmaceuticals Inc.</b>&nbsp;rose 51.2% to settle at $6.94 on above-average volume.</li>\n <li><b>Adicet Bio, Inc.</b>&nbsp;shares gained 38.5% to close at $13.57 after the company announced interim data from its dose escalation Phase 1 study evaluating the safety and tolerability of ADI-001.</li>\n <li><b>Advanced Human Imaging Limited</b>&nbsp;surged 30.9% to settle at $6.02.</li>\n <li><b>eFFECTOR Therapeutics, Inc.</b>&nbsp;gained 29.1% to close at $7.37.</li>\n <li><b>Cloopen Group Holding Limited</b>&nbsp;climbed 27% to settle at $3.43.</li>\n <li><b>Edgewise Therapeutics, Inc.</b>&nbsp;gained 22.8% to close at $18.42.</li>\n <li><b>GH Research PLC</b>&nbsp;gained 21.9% to close at $23.47 after the company reported better-than-expected Q3 EPS results.</li>\n <li><b>IN8bio, Inc.</b>&nbsp;rose 21.4% to close at $6.80. IN8bio, last month, named Trishna Goswami, M.D. as Chief Medical Officer.</li>\n <li><b>Liberty TripAdvisor Holdings, Inc.</b>&nbsp;gained 21.1% to close at $2.47.</li>\n <li><b>Progenity, Inc.</b>&nbsp;rose 19.5% to close at $2.82.</li>\n <li><b>Vasta Platform Limited</b>&nbsp;gained 18.8% to settle at $2.91.</li>\n <li><b>Xiaobai Maimai Inc.</b>&nbsp;rose 18% to close at $2.69.</li>\n <li><b>Atreca, Inc.</b>&nbsp;climbed 17.8% to settle at $3.38.</li>\n <li><b>Priority Technology Holdings, Inc.</b>&nbsp;rose 17.3% to close at $7.13.</li>\n <li><b>GCP Applied Technologies Inc.</b>&nbsp;gained 17.1% to close at $31.64. Saint-Gobain announced plans to buy GCP Applied Technologies in a deal valued at around $2.3 billion.</li>\n <li><b>FG Financial Group, Inc.</b>&nbsp;jumped 16.6% to settle at $3.79 as the company said its SPAC Platform partner, Aldel Financial has completed their previously announced business combination with Hagerty.</li>\n <li><b>Byrna Technologies Inc.</b>&nbsp;gained 16% to close at $15.16 after the company issued Q4 sales guidance above estimates and announced a $30 million buyback.</li>\n <li><b>Quoin Pharmaceuticals, Ltd.</b>&nbsp;rose 15.8% to close at $3.74.</li>\n <li><b>Kubient, Inc.</b>&nbsp;climbed 15.8% to close at $2.8250. Kubient, last month, posted a Q3 loss of $0.16 per share.</li>\n <li><b>KLX Energy Services Holdings, Inc.</b>&nbsp;gained 15.7% to settle at $3.57.</li>\n <li><b>North European Oil Royalty Trust</b>&nbsp;rose 14.8% to close at $9.86.</li>\n <li><b>Vicinity Motor Corp.</b>&nbsp;climbed 14.8% to close at $3.96.</li>\n <li><b>Offerpad Solutions Inc.</b>&nbsp;rose 14.8% to settle at $7.38.</li>\n <li><b>Sonendo, Inc.</b>&nbsp;gained 14.7% to close at $9.50.</li>\n <li><b>Twin Vee Powercats Co.</b>&nbsp;rose 13.8% to settle at $3.30.</li>\n <li><b>Recruiter.com Group, Inc.</b>&nbsp;rose 9.8% to close at $3.14.</li>\n <li><b>CF Acquisition Corp. VI</b>&nbsp;rose 6.7% to close at $12.70 on continued strength following the SPACs announcement of a merger with Rumble.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Bolt Biotherapeutics, Inc.</b>&nbsp;shares fell 55.8% to settle at $4.64 on Monday. Bolt Biotherapeutics announced the presentation of interim clinical data from its Phase 1/2 study of BDC-1001.</li>\n <li><b>Alset EHome International Inc.</b>&nbsp;shares dropped 41.7% to close at $0.6302 on Monday after the company priced its $30 million underwritten public offering.</li>\n <li><b>Reata Pharmaceuticals, Inc.</b>&nbsp;fell 37.8% to close at $48.92. Traders circulated the FDA briefing document saying 'FDA review team does not believe the submitted data demonstrate that bardoxolone is effective in slowing the loss of kidney function in patients with AS...'</li>\n <li><b>Aeglea BioTherapeutics, Inc.</b>&nbsp;declined 36.5% to close at $3.81 after the company announced data from the Phase 3 study of pegzilarginase in Arginase 1 Deficiency (ARG1-D) patients aged two years and older. ARG1-D is a rare disease characterized by high levels of the amino acid arginine. The disease manifestations include spasticity, developmental delay, intellectual disability, and seizures.</li>\n <li><b>MiNK Therapeutics, Inc.</b>&nbsp;fell 34.6% to settle at $6.85.</li>\n <li><b>Nam Tai Property Inc.</b>&nbsp;fell 29.8% to close at $10.00. Nam Tai Property confirmed results of special meeting of shareholders.</li>\n <li><b>Adagio Therapeutics, Inc.</b>&nbsp;dipped 29% to close at $32.53.</li>\n <li><b>Finch Therapeutics Group, Inc.</b>&nbsp;fell 28.4% to close at $10.97.</li>\n <li><b>Elevation Oncology, Inc.</b>&nbsp;fell 28.3% to close at $4.35.</li>\n <li><b>Arqit Quantum Inc.</b>&nbsp;dipped 27.6% to settle at $27.07 amid a rotation out of the space as well as a rise in treasury yields, which has pressured growth names.</li>\n <li><b>Creative Medical Technology Holdings, Inc.</b>&nbsp;dropped 27.4% to close at $1.62.</li>\n <li><b>Beyond Air, Inc.</b>&nbsp;fell 23.4% to close at $10.36.</li>\n <li><b>IsoPlexis Corporation</b>&nbsp;fell 22.7% to settle at $8.02.</li>\n <li><b>Pyxis Oncology, Inc.</b>&nbsp;dipped 20.9% to close at $9.64.</li>\n <li><b>POINT Biopharma Global Inc.</b>&nbsp;fell 20.9% to settle at $6.22.</li>\n <li><b>Imago BioSciences, Inc.</b>&nbsp;fell 20.6% to close at $16.22. Imago BioSciences, last month, posted a Q3 loss of $0.44 per share.</li>\n <li><b>OceanPal Inc.</b>&nbsp;fell 19.5% to settle at $3.30. OceanPal recently entered into a time charter trip contract for its Panamax dry bulk vessel, the m/v Calipso, a 73,691 dwt vessel built in 2005, at a gross charter rate of $18,750 per day, for about 15-20 days.</li>\n <li><b>BioNTech SE</b>&nbsp;dropped 18.7% to close at $279.83 as vaccine names pulled back after gaining in late November amid omicron concerns.</li>\n <li><b>Onion Global Limited</b>&nbsp;dipped 18% to settle at $3.18.</li>\n <li><b>uCloudlink Group Inc.</b>&nbsp;fell 17.5% to close at $2.31.</li>\n <li><b>Vaxxinity, Inc.</b>&nbsp;fell 17% to close at $7.32. B of A Securities initiated coverage on Vaxxinity with a Buy rating and announced a price target of $21.</li>\n <li><b>Entrada Therapeutics, Inc.</b>&nbsp;dropped 16.7% to settle at $22.26.</li>\n <li><b>Enjoy Technology, Inc.</b>&nbsp;declined 16.2% to close at $4.51.</li>\n <li><b>Bird Global, Inc.</b>&nbsp;fell 13.7% to close at $6.87.</li>\n <li><b>Moderna, Inc.</b>&nbsp;dipped 13.5% to close at $265.33. Moderna President Stephen Hoge said there’s a “real risk” that existing COVID-19 vaccines will be less effective against omicron, reported Bloomberg. In contrast, U.S. medical adviser Anthony Fauci said the variant’s severity might be limited.</li>\n <li><b>Kazia Therapeutics Limited</b>&nbsp;fell 13.4% to clsoe at $7.92.&nbsp;Kazia Therapeutics, last week announced&nbsp;final data from a Phase2 study&nbsp;of paxalisib as first-line therapy in patients with glioblastoma.</li>\n <li><b>AEye, Inc.</b>&nbsp;fell 12.7% to close at $4.60.</li>\n <li><b>Zscaler, Inc.</b>&nbsp;fell 12.4% to close at $274.36. Daiwa Capital downgraded Zscaler from Neutral to Underperform and announced a $286 price target.</li>\n <li><b>Erasca, Inc.</b>&nbsp;dropped 11.5% to close at $12.51. Erasca, last month, posted a Q3 loss of $0.46 per share.</li>\n <li><b>BuzzFeed</b>&nbsp;fell 11% to close at $8.56. The company has called itself \"the first publicly traded purely digital media company.\" Buzzfeed started trading on the Nasdaq on Monday.</li>\n <li><b>AST SpaceMobile, Inc.</b>&nbsp;shares fell 8.9% to close at $8.42. AST SpaceMobile, last month, posted Q3 EPS of $0.07 on sales of $2.45 million.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>60 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n60 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 18:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24474142/60-biggest-movers-from-yesterday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nInsignia Systems, Inc. shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24474142/60-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","BZFD":"Buzzfeed"},"source_url":"https://www.benzinga.com/news/21/12/24474142/60-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149974752","content_text":"Gainers\n\nInsignia Systems, Inc. shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.\nDel Taco Restaurants, Inc. shares climbed 66.1% to close at $12.51 on Monday.\nJack In The Box Inc agreed to acquire Del Taco Restaurants for $12.51 per share in cash in a deal valued at about $575 million.\nCumberland Pharmaceuticals Inc. rose 51.2% to settle at $6.94 on above-average volume.\nAdicet Bio, Inc. shares gained 38.5% to close at $13.57 after the company announced interim data from its dose escalation Phase 1 study evaluating the safety and tolerability of ADI-001.\nAdvanced Human Imaging Limited surged 30.9% to settle at $6.02.\neFFECTOR Therapeutics, Inc. gained 29.1% to close at $7.37.\nCloopen Group Holding Limited climbed 27% to settle at $3.43.\nEdgewise Therapeutics, Inc. gained 22.8% to close at $18.42.\nGH Research PLC gained 21.9% to close at $23.47 after the company reported better-than-expected Q3 EPS results.\nIN8bio, Inc. rose 21.4% to close at $6.80. IN8bio, last month, named Trishna Goswami, M.D. as Chief Medical Officer.\nLiberty TripAdvisor Holdings, Inc. gained 21.1% to close at $2.47.\nProgenity, Inc. rose 19.5% to close at $2.82.\nVasta Platform Limited gained 18.8% to settle at $2.91.\nXiaobai Maimai Inc. rose 18% to close at $2.69.\nAtreca, Inc. climbed 17.8% to settle at $3.38.\nPriority Technology Holdings, Inc. rose 17.3% to close at $7.13.\nGCP Applied Technologies Inc. gained 17.1% to close at $31.64. Saint-Gobain announced plans to buy GCP Applied Technologies in a deal valued at around $2.3 billion.\nFG Financial Group, Inc. jumped 16.6% to settle at $3.79 as the company said its SPAC Platform partner, Aldel Financial has completed their previously announced business combination with Hagerty.\nByrna Technologies Inc. gained 16% to close at $15.16 after the company issued Q4 sales guidance above estimates and announced a $30 million buyback.\nQuoin Pharmaceuticals, Ltd. rose 15.8% to close at $3.74.\nKubient, Inc. climbed 15.8% to close at $2.8250. Kubient, last month, posted a Q3 loss of $0.16 per share.\nKLX Energy Services Holdings, Inc. gained 15.7% to settle at $3.57.\nNorth European Oil Royalty Trust rose 14.8% to close at $9.86.\nVicinity Motor Corp. climbed 14.8% to close at $3.96.\nOfferpad Solutions Inc. rose 14.8% to settle at $7.38.\nSonendo, Inc. gained 14.7% to close at $9.50.\nTwin Vee Powercats Co. rose 13.8% to settle at $3.30.\nRecruiter.com Group, Inc. rose 9.8% to close at $3.14.\nCF Acquisition Corp. VI rose 6.7% to close at $12.70 on continued strength following the SPACs announcement of a merger with Rumble.\n\nLosers\n\nBolt Biotherapeutics, Inc. shares fell 55.8% to settle at $4.64 on Monday. Bolt Biotherapeutics announced the presentation of interim clinical data from its Phase 1/2 study of BDC-1001.\nAlset EHome International Inc. shares dropped 41.7% to close at $0.6302 on Monday after the company priced its $30 million underwritten public offering.\nReata Pharmaceuticals, Inc. fell 37.8% to close at $48.92. Traders circulated the FDA briefing document saying 'FDA review team does not believe the submitted data demonstrate that bardoxolone is effective in slowing the loss of kidney function in patients with AS...'\nAeglea BioTherapeutics, Inc. declined 36.5% to close at $3.81 after the company announced data from the Phase 3 study of pegzilarginase in Arginase 1 Deficiency (ARG1-D) patients aged two years and older. ARG1-D is a rare disease characterized by high levels of the amino acid arginine. The disease manifestations include spasticity, developmental delay, intellectual disability, and seizures.\nMiNK Therapeutics, Inc. fell 34.6% to settle at $6.85.\nNam Tai Property Inc. fell 29.8% to close at $10.00. Nam Tai Property confirmed results of special meeting of shareholders.\nAdagio Therapeutics, Inc. dipped 29% to close at $32.53.\nFinch Therapeutics Group, Inc. fell 28.4% to close at $10.97.\nElevation Oncology, Inc. fell 28.3% to close at $4.35.\nArqit Quantum Inc. dipped 27.6% to settle at $27.07 amid a rotation out of the space as well as a rise in treasury yields, which has pressured growth names.\nCreative Medical Technology Holdings, Inc. dropped 27.4% to close at $1.62.\nBeyond Air, Inc. fell 23.4% to close at $10.36.\nIsoPlexis Corporation fell 22.7% to settle at $8.02.\nPyxis Oncology, Inc. dipped 20.9% to close at $9.64.\nPOINT Biopharma Global Inc. fell 20.9% to settle at $6.22.\nImago BioSciences, Inc. fell 20.6% to close at $16.22. Imago BioSciences, last month, posted a Q3 loss of $0.44 per share.\nOceanPal Inc. fell 19.5% to settle at $3.30. OceanPal recently entered into a time charter trip contract for its Panamax dry bulk vessel, the m/v Calipso, a 73,691 dwt vessel built in 2005, at a gross charter rate of $18,750 per day, for about 15-20 days.\nBioNTech SE dropped 18.7% to close at $279.83 as vaccine names pulled back after gaining in late November amid omicron concerns.\nOnion Global Limited dipped 18% to settle at $3.18.\nuCloudlink Group Inc. fell 17.5% to close at $2.31.\nVaxxinity, Inc. fell 17% to close at $7.32. B of A Securities initiated coverage on Vaxxinity with a Buy rating and announced a price target of $21.\nEntrada Therapeutics, Inc. dropped 16.7% to settle at $22.26.\nEnjoy Technology, Inc. declined 16.2% to close at $4.51.\nBird Global, Inc. fell 13.7% to close at $6.87.\nModerna, Inc. dipped 13.5% to close at $265.33. Moderna President Stephen Hoge said there’s a “real risk” that existing COVID-19 vaccines will be less effective against omicron, reported Bloomberg. In contrast, U.S. medical adviser Anthony Fauci said the variant’s severity might be limited.\nKazia Therapeutics Limited fell 13.4% to clsoe at $7.92. Kazia Therapeutics, last week announced final data from a Phase2 study of paxalisib as first-line therapy in patients with glioblastoma.\nAEye, Inc. fell 12.7% to close at $4.60.\nZscaler, Inc. fell 12.4% to close at $274.36. Daiwa Capital downgraded Zscaler from Neutral to Underperform and announced a $286 price target.\nErasca, Inc. dropped 11.5% to close at $12.51. Erasca, last month, posted a Q3 loss of $0.46 per share.\nBuzzFeed fell 11% to close at $8.56. The company has called itself \"the first publicly traded purely digital media company.\" Buzzfeed started trading on the Nasdaq on Monday.\nAST SpaceMobile, Inc. shares fell 8.9% to close at $8.42. AST SpaceMobile, last month, posted Q3 EPS of $0.07 on sales of $2.45 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877683780,"gmtCreate":1637924524400,"gmtModify":1637924524523,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"😬😬","listText":"😬😬","text":"😬😬","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877683780","repostId":"1176160525","repostType":2,"repost":{"id":"1176160525","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637920107,"share":"https://www.laohu8.com/m/news/1176160525?lang=&edition=full","pubTime":"2021-11-26 17:48","market":"us","language":"zh","title":"盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮","url":"https://stock-news.laohu8.com/highlight/detail?id=1176160525","media":"老虎资讯综合","summary":"11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。\n\n美股区块链概念股盘前走低，Marathon Digital Holdings跌超8%，B","content":"<p>11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。</p>\n<p><img src=\"https://static.tigerbbs.com/5b49375b9c7bbdf2bc27f6abda87d2ef\" tg-width=\"385\" tg-height=\"191\" referrerpolicy=\"no-referrer\"></p>\n<p>美股区块链概念股盘前走低，<a href=\"https://laohu8.com/S/MARA\">Marathon Digital Holdings</a>跌超8%，<a href=\"https://laohu8.com/S/BTBT\">Bit Digital Inc</a>、<a href=\"https://laohu8.com/S/RIOT\">Riot Blockchain</a>、<a href=\"https://laohu8.com/S/CAN\">嘉楠科技</a>跌超7%，<a href=\"https://laohu8.com/S/SOS\">SOS Limited</a>跌超6%，<a href=\"https://laohu8.com/S/COIN\">Coinbase</a>跌超4%；</p>\n<p>美股油气板块盘前下挫，<a href=\"https://laohu8.com/S/CVE\">Cenovus能源</a>盘前跌8.88%，<a href=\"https://laohu8.com/S/BP\">英国石油</a>盘前跌6.5%，荷兰皇家壳牌盘前跌5.86%，<a href=\"https://laohu8.com/S/TTA.UK\">道达尔</a>、<a href=\"https://laohu8.com/S/XOM\">埃克森美孚</a>石油盘前跌5%，<a href=\"https://laohu8.com/S/CVX\">雪佛龙</a>盘前跌4.43%；</p>\n<p>美股抗疫概念股盘前走高，<a href=\"https://laohu8.com/S/AHPI\">联合保健产品</a>盘前涨超18%，Moderna盘前涨超10%，Ocugen盘前涨7.89%，<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>盘前涨6.9%，<a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯医药</a>盘前涨5.94%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>盘前涨超5%；</p>\n<p>美股大型科技股盘前普跌，<a href=\"https://laohu8.com/S/TSM\">台积电</a>、<a href=\"https://laohu8.com/S/NVDA\">英伟达</a>跌近3.5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌超3%，<a href=\"https://laohu8.com/S/MU\">美光科技</a>跌2.74%，<a href=\"https://laohu8.com/S/QCOM\">高通</a>、<a href=\"https://laohu8.com/S/FB\">Meta Platforms</a>跌超2%，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>、<a href=\"https://laohu8.com/S/INTC\">英特尔</a>跌1.9%，<a href=\"https://laohu8.com/S/CSCO\">思科</a>跌1.4%，<a href=\"https://laohu8.com/S/MSFT\">微软</a>跌1.04%；</p>\n<p>美股邮轮、航空股盘前集体重挫，<a href=\"https://laohu8.com/S/CCL\">嘉年华邮轮</a>跌超10%，<a href=\"https://laohu8.com/S/NCLH\">挪威邮轮</a>跌超7%；<a href=\"https://laohu8.com/S/DAL\">达美航空</a>、<a href=\"https://laohu8.com/S/UAL\">联合大陆航空</a>跌超7%，美国航空跌超5%；</p>\n<p>中概股盘前多数下跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>一度跌超8%；<a href=\"https://laohu8.com/S/KC\">金山云</a>跌6.73%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>跌6.36%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌5.6%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>、<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>跌超5%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌超4%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌近4.7%；</p>\n<p><a href=\"https://laohu8.com/S/FFIE\">法拉第未来</a>盘前跌5.5%，公司收到美国退市警告，要求60天内提交合规计划；</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a>盘前逆市拉升，涨超11%，ARK基金持续买入Zoom Video的股票。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮 </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮 \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-11-26 17:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。</p>\n<p><img src=\"https://static.tigerbbs.com/5b49375b9c7bbdf2bc27f6abda87d2ef\" tg-width=\"385\" tg-height=\"191\" referrerpolicy=\"no-referrer\"></p>\n<p>美股区块链概念股盘前走低，<a href=\"https://laohu8.com/S/MARA\">Marathon Digital Holdings</a>跌超8%，<a href=\"https://laohu8.com/S/BTBT\">Bit Digital Inc</a>、<a href=\"https://laohu8.com/S/RIOT\">Riot Blockchain</a>、<a href=\"https://laohu8.com/S/CAN\">嘉楠科技</a>跌超7%，<a href=\"https://laohu8.com/S/SOS\">SOS Limited</a>跌超6%，<a href=\"https://laohu8.com/S/COIN\">Coinbase</a>跌超4%；</p>\n<p>美股油气板块盘前下挫，<a href=\"https://laohu8.com/S/CVE\">Cenovus能源</a>盘前跌8.88%，<a href=\"https://laohu8.com/S/BP\">英国石油</a>盘前跌6.5%，荷兰皇家壳牌盘前跌5.86%，<a href=\"https://laohu8.com/S/TTA.UK\">道达尔</a>、<a href=\"https://laohu8.com/S/XOM\">埃克森美孚</a>石油盘前跌5%，<a href=\"https://laohu8.com/S/CVX\">雪佛龙</a>盘前跌4.43%；</p>\n<p>美股抗疫概念股盘前走高，<a href=\"https://laohu8.com/S/AHPI\">联合保健产品</a>盘前涨超18%，Moderna盘前涨超10%，Ocugen盘前涨7.89%，<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>盘前涨6.9%，<a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯医药</a>盘前涨5.94%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>盘前涨超5%；</p>\n<p>美股大型科技股盘前普跌，<a href=\"https://laohu8.com/S/TSM\">台积电</a>、<a href=\"https://laohu8.com/S/NVDA\">英伟达</a>跌近3.5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌超3%，<a href=\"https://laohu8.com/S/MU\">美光科技</a>跌2.74%，<a href=\"https://laohu8.com/S/QCOM\">高通</a>、<a href=\"https://laohu8.com/S/FB\">Meta Platforms</a>跌超2%，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>、<a href=\"https://laohu8.com/S/INTC\">英特尔</a>跌1.9%，<a href=\"https://laohu8.com/S/CSCO\">思科</a>跌1.4%，<a href=\"https://laohu8.com/S/MSFT\">微软</a>跌1.04%；</p>\n<p>美股邮轮、航空股盘前集体重挫，<a href=\"https://laohu8.com/S/CCL\">嘉年华邮轮</a>跌超10%，<a href=\"https://laohu8.com/S/NCLH\">挪威邮轮</a>跌超7%；<a href=\"https://laohu8.com/S/DAL\">达美航空</a>、<a href=\"https://laohu8.com/S/UAL\">联合大陆航空</a>跌超7%，美国航空跌超5%；</p>\n<p>中概股盘前多数下跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>一度跌超8%；<a href=\"https://laohu8.com/S/KC\">金山云</a>跌6.73%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>跌6.36%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌5.6%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>、<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>跌超5%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌超4%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌近4.7%；</p>\n<p><a href=\"https://laohu8.com/S/FFIE\">法拉第未来</a>盘前跌5.5%，公司收到美国退市警告，要求60天内提交合规计划；</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a>盘前逆市拉升，涨超11%，ARK基金持续买入Zoom Video的股票。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176160525","content_text":"11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。\n\n美股区块链概念股盘前走低，Marathon Digital Holdings跌超8%，Bit Digital Inc、Riot Blockchain、嘉楠科技跌超7%，SOS Limited跌超6%，Coinbase跌超4%；\n美股油气板块盘前下挫，Cenovus能源盘前跌8.88%，英国石油盘前跌6.5%，荷兰皇家壳牌盘前跌5.86%，道达尔、埃克森美孚石油盘前跌5%，雪佛龙盘前跌4.43%；\n美股抗疫概念股盘前走高，联合保健产品盘前涨超18%，Moderna盘前涨超10%，Ocugen盘前涨7.89%，BioNTech SE盘前涨6.9%，诺瓦瓦克斯医药盘前涨5.94%，辉瑞盘前涨超5%；\n美股大型科技股盘前普跌，台积电、英伟达跌近3.5%，特斯拉跌超3%，美光科技跌2.74%，高通、Meta Platforms跌超2%，苹果、英特尔跌1.9%，思科跌1.4%，微软跌1.04%；\n美股邮轮、航空股盘前集体重挫，嘉年华邮轮跌超10%，挪威邮轮跌超7%；达美航空、联合大陆航空跌超7%，美国航空跌超5%；\n中概股盘前多数下跌，滴滴一度跌超8%；金山云跌6.73%，好未来跌6.36%，爱奇艺跌5.6%，小鹏汽车、蔚来、贝壳跌超5%，阿里巴巴跌超4%，理想汽车跌近4.7%；\n法拉第未来盘前跌5.5%，公司收到美国退市警告，要求60天内提交合规计划；\nZoom盘前逆市拉升，涨超11%，ARK基金持续买入Zoom Video的股票。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878919440,"gmtCreate":1637136458239,"gmtModify":1637136458484,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"🤑🤑","listText":"🤑🤑","text":"🤑🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878919440","repostId":"1153997204","repostType":4,"isVote":1,"tweetType":1,"viewCount":1125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846918666,"gmtCreate":1636039126666,"gmtModify":1636040133341,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Earn &amp; redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&amp;Page=Me&amp;lang=en_US&amp;skin=1&amp;platform=ios&amp;invite=OX9U7S&amp;share=WhatsAPP#/","listText":"Earn &amp; redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&amp;Page=Me&amp;lang=en_US&amp;skin=1&amp;platform=ios&amp;invite=OX9U7S&amp;share=WhatsAPP#/","text":"Earn & redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&Page=Me&lang=en_US&skin=1&platform=ios&invite=OX9U7S&share=WhatsAPP#/","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846918666","isVote":1,"tweetType":1,"viewCount":1177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843487130,"gmtCreate":1635850675709,"gmtModify":1635850675814,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843487130","repostId":"1193558756","repostType":4,"repost":{"id":"1193558756","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635850584,"share":"https://www.laohu8.com/m/news/1193558756?lang=&edition=full","pubTime":"2021-11-02 18:56","market":"us","language":"en","title":"Pfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1193558756","media":"Tiger Newspress","summary":"Pfizer Inc on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 bi","content":"<p>Pfizer Inc&nbsp;on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.</p>\n<p>The company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech .</p>\n<p>Driven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.</p>\n<p>The company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.</p>\n<p>Pfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year.</p>\n<p>Its&nbsp;shares&nbsp;rose&nbsp;over 2% in premarket trading.<img src=\"https://static.tigerbbs.com/df663bc64292fce6036a0c102eb67471\" tg-width=\"770\" tg-height=\"566\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 18:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc&nbsp;on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.</p>\n<p>The company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech .</p>\n<p>Driven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.</p>\n<p>The company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.</p>\n<p>Pfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year.</p>\n<p>Its&nbsp;shares&nbsp;rose&nbsp;over 2% in premarket trading.<img src=\"https://static.tigerbbs.com/df663bc64292fce6036a0c102eb67471\" tg-width=\"770\" tg-height=\"566\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193558756","content_text":"Pfizer Inc on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.\nThe company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech .\nDriven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.\nThe company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.\nPfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year.\nIts shares rose over 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":908,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821433676,"gmtCreate":1633769530578,"gmtModify":1633769530578,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821433676","repostId":"1146175990","repostType":4,"isVote":1,"tweetType":1,"viewCount":1255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821430648,"gmtCreate":1633769450905,"gmtModify":1633769450905,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"&nbsp;okay","listText":"&nbsp;okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/821430648","repostId":"1135231383","repostType":4,"repost":{"id":"1135231383","kind":"news","pubTimestamp":1633746259,"share":"https://www.laohu8.com/m/news/1135231383?lang=&edition=full","pubTime":"2021-10-09 10:24","market":"us","language":"en","title":"NVIDIA acquires formal verification firm Oski Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1135231383","media":"seekingalpha","summary":"Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nF","content":"<ul>\n <li>Visual computing company NVIDIA(NASDAQ:NVDA)has&nbsp;acquired&nbsp;formal verification firm Oski Technology.</li>\n <li>Founded in 2005, Oski specializes in formal verification methods and has been a long-standing partner to NVIDIA for more than 10 years. The company operates offices in San Jose, Budapest and Gurgaon.</li>\n <li>As NVIDIA's products have grown in complexity and scope, now spanning markets from gaming and data center computing to networking and autonomous vehicles, the importance of designing perfect first silicon has never been higher. And new autonomous machine applications where safety is the highest goal make verification vital.</li>\n <li>The Oski&nbsp;acquisition will enable NVIDIA to significantly increase its investment in formal verification strategies to achieve that goal.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NVIDIA acquires formal verification firm Oski Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNVIDIA acquires formal verification firm Oski Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nFounded in 2005, Oski specializes in formal verification methods and has been a long-standing partner...</p>\n\n<a href=\"https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135231383","content_text":"Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nFounded in 2005, Oski specializes in formal verification methods and has been a long-standing partner to NVIDIA for more than 10 years. The company operates offices in San Jose, Budapest and Gurgaon.\nAs NVIDIA's products have grown in complexity and scope, now spanning markets from gaming and data center computing to networking and autonomous vehicles, the importance of designing perfect first silicon has never been higher. And new autonomous machine applications where safety is the highest goal make verification vital.\nThe Oski acquisition will enable NVIDIA to significantly increase its investment in formal verification strategies to achieve that goal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821430954,"gmtCreate":1633769438297,"gmtModify":1633769438297,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"&nbsp;okay","listText":"&nbsp;okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821430954","repostId":"1135231383","repostType":4,"repost":{"id":"1135231383","kind":"news","pubTimestamp":1633746259,"share":"https://www.laohu8.com/m/news/1135231383?lang=&edition=full","pubTime":"2021-10-09 10:24","market":"us","language":"en","title":"NVIDIA acquires formal verification firm Oski Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1135231383","media":"seekingalpha","summary":"Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nF","content":"<ul>\n <li>Visual computing company NVIDIA(NASDAQ:NVDA)has&nbsp;acquired&nbsp;formal verification firm Oski Technology.</li>\n <li>Founded in 2005, Oski specializes in formal verification methods and has been a long-standing partner to NVIDIA for more than 10 years. The company operates offices in San Jose, Budapest and Gurgaon.</li>\n <li>As NVIDIA's products have grown in complexity and scope, now spanning markets from gaming and data center computing to networking and autonomous vehicles, the importance of designing perfect first silicon has never been higher. And new autonomous machine applications where safety is the highest goal make verification vital.</li>\n <li>The Oski&nbsp;acquisition will enable NVIDIA to significantly increase its investment in formal verification strategies to achieve that goal.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NVIDIA acquires formal verification firm Oski Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNVIDIA acquires formal verification firm Oski Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nFounded in 2005, Oski specializes in formal verification methods and has been a long-standing partner...</p>\n\n<a href=\"https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135231383","content_text":"Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nFounded in 2005, Oski specializes in formal verification methods and has been a long-standing partner to NVIDIA for more than 10 years. The company operates offices in San Jose, Budapest and Gurgaon.\nAs NVIDIA's products have grown in complexity and scope, now spanning markets from gaming and data center computing to networking and autonomous vehicles, the importance of designing perfect first silicon has never been higher. And new autonomous machine applications where safety is the highest goal make verification vital.\nThe Oski acquisition will enable NVIDIA to significantly increase its investment in formal verification strategies to achieve that goal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861889543,"gmtCreate":1632482046782,"gmtModify":1632719314508,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861889543","repostId":"1147407851","repostType":4,"repost":{"id":"1147407851","kind":"news","pubTimestamp":1632476902,"share":"https://www.laohu8.com/m/news/1147407851?lang=&edition=full","pubTime":"2021-09-24 17:48","market":"us","language":"en","title":"EU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1147407851","media":"zerohedge","summary":"In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing","content":"<p>In keeping with their more cautious approach toward approving COVID jabs,<b>EU regulators are preparing to make their own decisions about whether to approve booster shots with Pfizer jab</b>s - but not until early October,Reuters reportedThursday.</p>\n<p>Reuters pointed out that<b>the upcoming review of the Pfizer booster jab would mark the European regulators' first decision about doling out booster jabs</b>in the EU.</p>\n<p>In an opinion issued earlier this month that was republished by the EMA,<b>the European Center for Disease Prevention and Control</b>- or ECDC, one of several regulators that comprises the EU's highest-level of health regulators -<b>said there was no \"urgent need\" to administer booster doses</b>to fully vaccinated individuals in the general population.</p>\n<p>But it also noted that additional doses are already being considered and doled out to the elderly, the immuno-compromised, and whatever</p>\n<p>Regardless of whatever the bloc decides,<b>it has already signed recent deals with Pfizer and BioNTech for 2.4 billion more mRNA jabs.</b></p>\n<p>The latest contract covers the supply of at least 900MM shots, which will only be needed if the EU goes ahead with expansive booster jab program and offers them to all adults 16 and up. . Over 70% of the EU's adult population has already been fully vaccinated, and the bloc has secured an ample supply of vaccines from several manufacturers.</p>\n<p>Still, as the delta wave continues to create problems for politicians around the world, they might grow increasingly desperate to force the population to get 3, 4 or even 5 jabs - despite the fact that The ECDC has said crucial data on the need and safety of boosters hasn't yet been gleaned from the studies unfurling around the world rfhr n in part because it is not yet fully clear how long vaccines protect against the virus.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 17:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/geopolitical/eu-will-wait-decide-pfizer-boosters-due-shortage-safety-data?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing to make their own decisions about whether to approve booster shots with Pfizer jabs - but not until...</p>\n\n<a href=\"https://www.zerohedge.com/geopolitical/eu-will-wait-decide-pfizer-boosters-due-shortage-safety-data?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.zerohedge.com/geopolitical/eu-will-wait-decide-pfizer-boosters-due-shortage-safety-data?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147407851","content_text":"In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing to make their own decisions about whether to approve booster shots with Pfizer jabs - but not until early October,Reuters reportedThursday.\nReuters pointed out thatthe upcoming review of the Pfizer booster jab would mark the European regulators' first decision about doling out booster jabsin the EU.\nIn an opinion issued earlier this month that was republished by the EMA,the European Center for Disease Prevention and Control- or ECDC, one of several regulators that comprises the EU's highest-level of health regulators -said there was no \"urgent need\" to administer booster dosesto fully vaccinated individuals in the general population.\nBut it also noted that additional doses are already being considered and doled out to the elderly, the immuno-compromised, and whatever\nRegardless of whatever the bloc decides,it has already signed recent deals with Pfizer and BioNTech for 2.4 billion more mRNA jabs.\nThe latest contract covers the supply of at least 900MM shots, which will only be needed if the EU goes ahead with expansive booster jab program and offers them to all adults 16 and up. . Over 70% of the EU's adult population has already been fully vaccinated, and the bloc has secured an ample supply of vaccines from several manufacturers.\nStill, as the delta wave continues to create problems for politicians around the world, they might grow increasingly desperate to force the population to get 3, 4 or even 5 jabs - despite the fact that The ECDC has said crucial data on the need and safety of boosters hasn't yet been gleaned from the studies unfurling around the world rfhr n in part because it is not yet fully clear how long vaccines protect against the virus.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":885675824,"gmtCreate":1631792999268,"gmtModify":1631889843280,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/885675824","repostId":"2167351025","repostType":4,"isVote":1,"tweetType":1,"viewCount":770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882253545,"gmtCreate":1631698884587,"gmtModify":1631889843283,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882253545","repostId":"1108272392","repostType":4,"repost":{"id":"1108272392","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631693345,"share":"https://www.laohu8.com/m/news/1108272392?lang=&edition=full","pubTime":"2021-09-15 16:09","market":"us","language":"en","title":"Apple shares rose 0.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1108272392","media":"Tiger Newspress","summary":"Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the new iPhone 13 in","content":"<p>Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the&nbsp;new iPhone 13 in all of its versions were unveiled. The stock closed down 0.96% at $148.12.</p>\n<p><img src=\"https://static.tigerbbs.com/43a1bc16e540f70c96b045c162ee647d\" tg-width=\"850\" tg-height=\"638\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose 0.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose 0.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 16:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the&nbsp;new iPhone 13 in all of its versions were unveiled. The stock closed down 0.96% at $148.12.</p>\n<p><img src=\"https://static.tigerbbs.com/43a1bc16e540f70c96b045c162ee647d\" tg-width=\"850\" tg-height=\"638\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108272392","content_text":"Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the new iPhone 13 in all of its versions were unveiled. The stock closed down 0.96% at $148.12.","news_type":1},"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883977110,"gmtCreate":1631199093330,"gmtModify":1631889843287,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"woww","listText":"woww","text":"woww","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883977110","repostId":"1171758120","repostType":4,"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813515941,"gmtCreate":1630213493183,"gmtModify":1704957130540,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Hmm🤔","listText":"Hmm🤔","text":"Hmm🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/813515941","repostId":"2162358024","repostType":4,"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833715618,"gmtCreate":1629262714834,"gmtModify":1631889843295,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Woww","listText":"Woww","text":"Woww","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/833715618","repostId":"2160781981","repostType":4,"isVote":1,"tweetType":1,"viewCount":337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830364522,"gmtCreate":1629014165466,"gmtModify":1631889843297,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/830364522","repostId":"1127633167","repostType":4,"repost":{"id":"1127633167","kind":"news","pubTimestamp":1628997765,"share":"https://www.laohu8.com/m/news/1127633167?lang=&edition=full","pubTime":"2021-08-15 11:22","market":"us","language":"en","title":"These 10 Standout Stocks Could Be the Next Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=1127633167","media":"Barrons","summary":"One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors loo","content":"<p>One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of generating double-digit compound growth in revenue and earnings—preferably both—for years to come.</p>\n<p>The idea is that stock prices should compound in line with revenue and profits, enabling investors to generate high returns over a holding period of five to 10 years. The ultimate goal is to find the elusive “10 bagger”—a stock&nbsp;that returns 10 times what you paid for it.</p>\n<p>Wall Street analyst notes and client letters from investment pros are replete with compounder references. Many of the next generation of value managers, identified&nbsp;in a&nbsp;<i>Barron’s</i>&nbsp;cover story in May, are seeking such shares, rather than the traditional value fare of cheap stocks.</p>\n<p>Their search has become more challenging, because buyers are paying lofty prices for high-growth stories. Really big winners are scarce. Only about 35 companies in each of a long series of 10-year periods have compounded their stock prices at 20% or more annually, resulting in at least a sixfold increase, according to Durable Capital Partners.</p>\n<p>Many investors are happy to stick with large, well-known compounders, such as&nbsp;Alphabet(ticker: GOOGL),Mastercard(MA),UnitedHealth Group(UNH), and&nbsp;Eli Lilly(LLY).</p>\n<p><i>Barron’s</i>&nbsp;sought to identify smaller candidates. We talked to investment managers and came up with an eclectic list of 10 stocks, most with market values under $10 billion. Here are the selections, in alphabetical order:</p>\n<p>Strong and Steady Wins the RaceHere are 10 stocks that growth investors have identified as being able to generate consistently high growth in revenues or profits for many years.</p>\n<table>\n <thead>\n  <tr>\n   <th>Company / Ticker</th>\n   <th>Recent Price</th>\n   <th>YTD Change</th>\n   <th>2021E P/E</th>\n   <th>2021E Price/Sales</th>\n   <th>2022E P/E</th>\n   <th>2022E Price/Sales</th>\n   <th>LT Growth Rate*</th>\n   <th>Market Value (bil)</th>\n   <th>Comment</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Amedysis / AMED</td>\n   <td>$185.15</td>\n   <td>-37%</td>\n   <td>30.2</td>\n   <td>2.7</td>\n   <td>27.7</td>\n   <td>2.4</td>\n   <td>10.5%</td>\n   <td>$6.3</td>\n   <td>Leader in home health care</td>\n  </tr>\n  <tr>\n   <td>Amyris / AMRS</td>\n   <td>13.64</td>\n   <td>121</td>\n   <td>NM</td>\n   <td>10.4</td>\n   <td>NM</td>\n   <td>9.7</td>\n   <td>NA</td>\n   <td>4.1</td>\n   <td>Leading company in synthetic biology</td>\n  </tr>\n  <tr>\n   <td>Booz Allen Hamilton Holding / BAH</td>\n   <td>81.73</td>\n   <td>-6</td>\n   <td>19.4</td>\n   <td>1.3</td>\n   <td>17.7</td>\n   <td>1.2</td>\n   <td>8.6</td>\n   <td>11.0</td>\n   <td>Defense-department consultant</td>\n  </tr>\n  <tr>\n   <td>J.B. Hunt Transport Services / JBHT</td>\n   <td>172.76</td>\n   <td>26</td>\n   <td>25.8</td>\n   <td>1.5</td>\n   <td>22.2</td>\n   <td>1.4</td>\n   <td>18.4</td>\n   <td>18.2</td>\n   <td>Strong in intermodal freight</td>\n  </tr>\n  <tr>\n   <td>Marriott Vacations Worldwide / VAC</td>\n   <td>147.15</td>\n   <td>7</td>\n   <td>40.9</td>\n   <td>1.6</td>\n   <td>15.7</td>\n   <td>1.4</td>\n   <td>NA</td>\n   <td>6.3</td>\n   <td>Top company in vacation timeshares</td>\n  </tr>\n  <tr>\n   <td>SiteOne Landscape Supply / SITE</td>\n   <td>197.10</td>\n   <td>24</td>\n   <td>45.7</td>\n   <td>2.6</td>\n   <td>43.5</td>\n   <td>2.5</td>\n   <td>19.3</td>\n   <td>8.8</td>\n   <td>Big supplier of landscaping supplies</td>\n  </tr>\n  <tr>\n   <td>Staar Surgical / STAA</td>\n   <td>138.19</td>\n   <td>74</td>\n   <td>192.3</td>\n   <td>28.6</td>\n   <td>140.8</td>\n   <td>22.5</td>\n   <td>30.0</td>\n   <td>6.6</td>\n   <td>Maker of implantable lens for myopia</td>\n  </tr>\n  <tr>\n   <td>Stitch Fix / SFIX</td>\n   <td>44.38</td>\n   <td>-24</td>\n   <td>NM</td>\n   <td>1.9</td>\n   <td>1890.3</td>\n   <td>1.7</td>\n   <td>30.0</td>\n   <td>4.8</td>\n   <td>Data-driven subscription clothing firm</td>\n  </tr>\n  <tr>\n   <td>Trex / TREX</td>\n   <td>105.94</td>\n   <td>27</td>\n   <td>51.9</td>\n   <td>10.5</td>\n   <td>43.6</td>\n   <td>9.3</td>\n   <td>18.8</td>\n   <td>12.2</td>\n   <td>Top maker of synthetic wood decking</td>\n  </tr>\n  <tr>\n   <td>Upwork / UPWK</td>\n   <td>44.31</td>\n   <td>28</td>\n   <td>NM</td>\n   <td>11.4</td>\n   <td>556.8</td>\n   <td>9.2</td>\n   <td>NA</td>\n   <td>5.7</td>\n   <td>Online clearinghouse for free-lancers</td>\n  </tr>\n </tbody>\n</table>\n<p>E=Estimate. BAH estimates are for fiscal years ending March 2022 and March 23. SFIX estimates are for fiscal years ending July 2022 and July 2023. NM=Not Meaningful. NA=Not Available. *The annual EPS growth the company can sustain over the next 3-5 years.</p>\n<p>Source: FactSet</p>\n<p>Amedisys(AMED), a provider of home healthcare and hospice services, has a national footprint in a still-fragmented business.</p>\n<p>“There is going to be massive consolidation of the industry” predicts Dan Cole, a manager of the Columbia Small-Cap Growth fund. “Healthcare is moving to the home.”</p>\n<p>Amedisys stock is up more than tenfold in the past decade. But the shares, around $185, are off nearly 30% after the company recently cut 2021 financial guidance, citing Covid-related staffing and cost issues, mostly in acquired hospice operations. The 2021 earnings estimate is now $6.13 a share, down from nearly $7. The stock trades for 30 times projected 2021 profits. Cole says that the company remains capable of generating 10% annual gains in earnings per share.</p>\n<p>Amyris(AMRS) is a leader in synthetic biology. It fans say its opportunity is to supplant, in an eco-friendly way, a range of products now made from petrochemicals, animals, and plants.</p>\n<p>Using genetically re-engineered yeast and sugar cane, Amyris produces such things as squalane, a high-end moisturizer formerly made from shark livers; vanillin, the flavoring for vanilla; and a no-calorie sweetener normally derived from plants. The stock trades around $13.</p>\n<p><i>Barron’s</i>&nbsp;wrote&nbsp;favorably on the company in July. Amyris sees sales reaching $2 billion by 2025, up from an estimated $400 million this year, driven by its consumer brands.</p>\n<p>“The world needs clean chemistry, and Amyris is the point on the spear to create it,” says Randy Baron, a portfolio manager at Pinnacle Associates, which owns Amyris shares. He thinks they could hit $75 by the end of 2022.</p>\n<p>Booz Allen Hamilton Holding(BAH) is an important consultant to the Defense Department and other agencies. The U.S. government accounted for 97% of its revenue in its latest fiscal year. Booz Allen has built robust ties to the government over the years by providing an array of services, like cybersecurity. Its stock trades around $81, for a 1.8% yield.</p>\n<p>“It has built a strong, partnership-like culture and has a long record of steady growth,” says Josh Spencer, manager of the T. Rowe Price New Horizons fund. He sees Booz Allen as capable of generating 9% to 10% annual growth in revenue and yearly gains of 15% to 16% in earnings, in line with its historical performance. The stock is off 20% from its peak of $100, amid concerns about more restrained military spending. Spencer sees the pullback as a buying opportunity, with the stock valued at less than 20 times earnings.</p>\n<p>J.B. Hunt Transport Services(JBHT) is a leader in intermodal freight, which involves the fuel-efficient movement of trucks over rail lines. It has been one of the most successful trucking companies. Its stock has risen 30-fold over the past 20 years, to a recent $173. “It has an incredible franchise,” says Henry Ellenbogen, chief investment officer at Durable Capital Partners and a member of the&nbsp;Barron’s Roundtable.</p>\n<p>J.B. Hunt’s relationship with the Burlington Northern Santa Fe railroad gives it a strong position in intermodal freight, he notes. J.B. Hunt also has a growing business taking over the trucking operations of smaller companies. And it is involved in digital freight brokerage—matching truckers with shipping customers.</p>\n<p>Ellenbogen says the stock is reasonable at 22 times estimated 2022 profits, given a mid-teens annual growth outlook for earnings.</p>\n<p>Marriott Vacations Worldwide(VAC) is one of the top companies in the timeshare industry. It has 700,000 owners, a resilient business model with significant revenue from fees, and more exposure than its peers to luxury properties in places including Hawaii and Orlando, Fla.</p>\n<p>“It has the best customer base, with the highest spending and an impeccable balance sheet,” says David Baron, a manager of the Baron Focused Growth fund. Marriott Vacations, whose shares recently were trading around $145, should reinstate its dividend later this year, he adds.</p>\n<p>The shares, Baron argues, are cheap at a 11% free-cash-flow yield, based on 2022 estimates. He says that the stock, little changed since 2018, could produce 20% annual returns for shareholders in the coming years.</p>\n<p>SiteOne Landscape Supply(SITE) is the country’s top supplier of landscaping products, with ample opportunity to expand, given that it has just a 13% market share in a highly fragmented industry.</p>\n<p></p>\n<p>“It’s growing organically and has lots of acquisition opportunities,” says Columbia’s Cole, who considers the company to be capable of 10% to 15% annual revenue growth.</p>\n<p>The stock, around $197, has a rich valuation, trading for 43 times projected 2022 earnings of $4.54 a share.</p>\n<p>Staar Surgical(STAA) has developed an implantable lens to correct myopia (nearsightedness). That addresses a potentially huge market, given the rising global incidence of that vision problem. The company expects the lens, which has been available in Europe and Asia for at least five years, to be on the U.S. market in the fourth quarter, pending Food and Drug Administration approval.</p>\n<p>“It could do substantial volumes,’’ says Doug Brodie, a global manager at Baillie Gifford. “It’s early in a journey and is largely devoid of competition.”</p>\n<p>Lenses for both eyes can be implanted in less than an hour, and they don’t involve the removal of the natural lenses. The wholesale cost in the U.S. could be around $1,000 per lens.</p>\n<p>At a recent $138, Staar shares are richly valued at more than 20 times projected 2022 sales and 140 times estimated 2022 earnings. But the market opportunity is enormous: Some five billion people worldwide could have myopia by 2050.</p>\n<p>Stitch Fix(SFIX) has developed a subscription service for clothing, shoes, and other accessories and boasts over four million customers.</p>\n<p>“This could be the Nordstrom of the future,” says Mario Cibelli, chief investment officer at Marathon Partners Equity Management, a Stitch Fix holder. “This a potentially huge market and nobody is addressing it in the same way.” Using a staff of 6,000 personal stylists and lots of data, Stitch Fix seeks to identify subscriber tastes to generate high satisfaction and limit returns on packages sent at intervals and determined by subscribers.</p>\n<p>Its shares, around $44, are down 60% from their level earlier in the year, on investors’ worries about potential churn and the business’s ultimate profitability.</p>\n<p>Yet Cibelli sees revenue growth of 20%-plus annually, opportunities outside its current U.S. and U.K. markets, and a potentially very profitable business in two to three years.</p>\n<p>Trex(TREX) is the top producer of a high-end wood alternative for decks that comes from 95% recycled material, making it an eco-friendly housing play. The shares, at $105, trade for 43 times projected 2022 earnings.</p>\n<p>T. Rowe Price’s Spencer views Trex as worth the price, based on his view that it can generate sustainable annual revenue growth of 15% to 20%. Earnings are expected to climb by about 20% in 2022 and at a similar pace in the following years. “If you roll the clock forward three years, it doesn’t look as expensive,” he says.</p>\n<p>Upwork(UPWK), an online marketplace for freelance workers, is favored by Baillie Gifford’s Brodie, who says it offers a play on the greater acceptance of freelancers by businesses.</p>\n<p>The shares, recently around $44, aren’t cheap. Upwork is valued at $5.7 billion, or more than 10 times this year’s projected sales of nearly $500 million. It operates at a slight loss.</p>\n<p>The investment case is about rapid sales growth leading to ample earnings. Sales are expected to rise by 30%-plus this year and 25% for 2022.</p>\n<p>“Freelancers are more accepted by small to midsize business, but they’ve been frowned on by the HR departments at large businesses,” Brodie says. Upwork aims to change that perception by vetting its freelancers and by offering thousands of skill sets. “Upwork could become a trusted partner for an increasing number of enterprise-grade partners,” he says.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 10 Standout Stocks Could Be the Next Amazon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 10 Standout Stocks Could Be the Next Amazon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-15 11:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of ...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMED":"阿米斯医疗","VAC":"万豪度假环球","TREX":"Trex Co Inc","SFIX":"Stitch Fix Inc.","BAH":"博思艾伦咨询公司","SITE":"SiteOne Landscape Supply, Inc.","AMRS":"阿米瑞斯","STAA":"STAAR Surgical Company","UPWK":"Upwork Inc.","JBHT":"JB Hunt运输服务"},"source_url":"https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127633167","content_text":"One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of generating double-digit compound growth in revenue and earnings—preferably both—for years to come.\nThe idea is that stock prices should compound in line with revenue and profits, enabling investors to generate high returns over a holding period of five to 10 years. The ultimate goal is to find the elusive “10 bagger”—a stock that returns 10 times what you paid for it.\nWall Street analyst notes and client letters from investment pros are replete with compounder references. Many of the next generation of value managers, identified in a Barron’s cover story in May, are seeking such shares, rather than the traditional value fare of cheap stocks.\nTheir search has become more challenging, because buyers are paying lofty prices for high-growth stories. Really big winners are scarce. Only about 35 companies in each of a long series of 10-year periods have compounded their stock prices at 20% or more annually, resulting in at least a sixfold increase, according to Durable Capital Partners.\nMany investors are happy to stick with large, well-known compounders, such as Alphabet(ticker: GOOGL),Mastercard(MA),UnitedHealth Group(UNH), and Eli Lilly(LLY).\nBarron’s sought to identify smaller candidates. We talked to investment managers and came up with an eclectic list of 10 stocks, most with market values under $10 billion. Here are the selections, in alphabetical order:\nStrong and Steady Wins the RaceHere are 10 stocks that growth investors have identified as being able to generate consistently high growth in revenues or profits for many years.\n\n\n\nCompany / Ticker\nRecent Price\nYTD Change\n2021E P/E\n2021E Price/Sales\n2022E P/E\n2022E Price/Sales\nLT Growth Rate*\nMarket Value (bil)\nComment\n\n\n\n\nAmedysis / AMED\n$185.15\n-37%\n30.2\n2.7\n27.7\n2.4\n10.5%\n$6.3\nLeader in home health care\n\n\nAmyris / AMRS\n13.64\n121\nNM\n10.4\nNM\n9.7\nNA\n4.1\nLeading company in synthetic biology\n\n\nBooz Allen Hamilton Holding / BAH\n81.73\n-6\n19.4\n1.3\n17.7\n1.2\n8.6\n11.0\nDefense-department consultant\n\n\nJ.B. Hunt Transport Services / JBHT\n172.76\n26\n25.8\n1.5\n22.2\n1.4\n18.4\n18.2\nStrong in intermodal freight\n\n\nMarriott Vacations Worldwide / VAC\n147.15\n7\n40.9\n1.6\n15.7\n1.4\nNA\n6.3\nTop company in vacation timeshares\n\n\nSiteOne Landscape Supply / SITE\n197.10\n24\n45.7\n2.6\n43.5\n2.5\n19.3\n8.8\nBig supplier of landscaping supplies\n\n\nStaar Surgical / STAA\n138.19\n74\n192.3\n28.6\n140.8\n22.5\n30.0\n6.6\nMaker of implantable lens for myopia\n\n\nStitch Fix / SFIX\n44.38\n-24\nNM\n1.9\n1890.3\n1.7\n30.0\n4.8\nData-driven subscription clothing firm\n\n\nTrex / TREX\n105.94\n27\n51.9\n10.5\n43.6\n9.3\n18.8\n12.2\nTop maker of synthetic wood decking\n\n\nUpwork / UPWK\n44.31\n28\nNM\n11.4\n556.8\n9.2\nNA\n5.7\nOnline clearinghouse for free-lancers\n\n\n\nE=Estimate. BAH estimates are for fiscal years ending March 2022 and March 23. SFIX estimates are for fiscal years ending July 2022 and July 2023. NM=Not Meaningful. NA=Not Available. *The annual EPS growth the company can sustain over the next 3-5 years.\nSource: FactSet\nAmedisys(AMED), a provider of home healthcare and hospice services, has a national footprint in a still-fragmented business.\n“There is going to be massive consolidation of the industry” predicts Dan Cole, a manager of the Columbia Small-Cap Growth fund. “Healthcare is moving to the home.”\nAmedisys stock is up more than tenfold in the past decade. But the shares, around $185, are off nearly 30% after the company recently cut 2021 financial guidance, citing Covid-related staffing and cost issues, mostly in acquired hospice operations. The 2021 earnings estimate is now $6.13 a share, down from nearly $7. The stock trades for 30 times projected 2021 profits. Cole says that the company remains capable of generating 10% annual gains in earnings per share.\nAmyris(AMRS) is a leader in synthetic biology. It fans say its opportunity is to supplant, in an eco-friendly way, a range of products now made from petrochemicals, animals, and plants.\nUsing genetically re-engineered yeast and sugar cane, Amyris produces such things as squalane, a high-end moisturizer formerly made from shark livers; vanillin, the flavoring for vanilla; and a no-calorie sweetener normally derived from plants. The stock trades around $13.\nBarron’s wrote favorably on the company in July. Amyris sees sales reaching $2 billion by 2025, up from an estimated $400 million this year, driven by its consumer brands.\n“The world needs clean chemistry, and Amyris is the point on the spear to create it,” says Randy Baron, a portfolio manager at Pinnacle Associates, which owns Amyris shares. He thinks they could hit $75 by the end of 2022.\nBooz Allen Hamilton Holding(BAH) is an important consultant to the Defense Department and other agencies. The U.S. government accounted for 97% of its revenue in its latest fiscal year. Booz Allen has built robust ties to the government over the years by providing an array of services, like cybersecurity. Its stock trades around $81, for a 1.8% yield.\n“It has built a strong, partnership-like culture and has a long record of steady growth,” says Josh Spencer, manager of the T. Rowe Price New Horizons fund. He sees Booz Allen as capable of generating 9% to 10% annual growth in revenue and yearly gains of 15% to 16% in earnings, in line with its historical performance. The stock is off 20% from its peak of $100, amid concerns about more restrained military spending. Spencer sees the pullback as a buying opportunity, with the stock valued at less than 20 times earnings.\nJ.B. Hunt Transport Services(JBHT) is a leader in intermodal freight, which involves the fuel-efficient movement of trucks over rail lines. It has been one of the most successful trucking companies. Its stock has risen 30-fold over the past 20 years, to a recent $173. “It has an incredible franchise,” says Henry Ellenbogen, chief investment officer at Durable Capital Partners and a member of the Barron’s Roundtable.\nJ.B. Hunt’s relationship with the Burlington Northern Santa Fe railroad gives it a strong position in intermodal freight, he notes. J.B. Hunt also has a growing business taking over the trucking operations of smaller companies. And it is involved in digital freight brokerage—matching truckers with shipping customers.\nEllenbogen says the stock is reasonable at 22 times estimated 2022 profits, given a mid-teens annual growth outlook for earnings.\nMarriott Vacations Worldwide(VAC) is one of the top companies in the timeshare industry. It has 700,000 owners, a resilient business model with significant revenue from fees, and more exposure than its peers to luxury properties in places including Hawaii and Orlando, Fla.\n“It has the best customer base, with the highest spending and an impeccable balance sheet,” says David Baron, a manager of the Baron Focused Growth fund. Marriott Vacations, whose shares recently were trading around $145, should reinstate its dividend later this year, he adds.\nThe shares, Baron argues, are cheap at a 11% free-cash-flow yield, based on 2022 estimates. He says that the stock, little changed since 2018, could produce 20% annual returns for shareholders in the coming years.\nSiteOne Landscape Supply(SITE) is the country’s top supplier of landscaping products, with ample opportunity to expand, given that it has just a 13% market share in a highly fragmented industry.\n\n“It’s growing organically and has lots of acquisition opportunities,” says Columbia’s Cole, who considers the company to be capable of 10% to 15% annual revenue growth.\nThe stock, around $197, has a rich valuation, trading for 43 times projected 2022 earnings of $4.54 a share.\nStaar Surgical(STAA) has developed an implantable lens to correct myopia (nearsightedness). That addresses a potentially huge market, given the rising global incidence of that vision problem. The company expects the lens, which has been available in Europe and Asia for at least five years, to be on the U.S. market in the fourth quarter, pending Food and Drug Administration approval.\n“It could do substantial volumes,’’ says Doug Brodie, a global manager at Baillie Gifford. “It’s early in a journey and is largely devoid of competition.”\nLenses for both eyes can be implanted in less than an hour, and they don’t involve the removal of the natural lenses. The wholesale cost in the U.S. could be around $1,000 per lens.\nAt a recent $138, Staar shares are richly valued at more than 20 times projected 2022 sales and 140 times estimated 2022 earnings. But the market opportunity is enormous: Some five billion people worldwide could have myopia by 2050.\nStitch Fix(SFIX) has developed a subscription service for clothing, shoes, and other accessories and boasts over four million customers.\n“This could be the Nordstrom of the future,” says Mario Cibelli, chief investment officer at Marathon Partners Equity Management, a Stitch Fix holder. “This a potentially huge market and nobody is addressing it in the same way.” Using a staff of 6,000 personal stylists and lots of data, Stitch Fix seeks to identify subscriber tastes to generate high satisfaction and limit returns on packages sent at intervals and determined by subscribers.\nIts shares, around $44, are down 60% from their level earlier in the year, on investors’ worries about potential churn and the business’s ultimate profitability.\nYet Cibelli sees revenue growth of 20%-plus annually, opportunities outside its current U.S. and U.K. markets, and a potentially very profitable business in two to three years.\nTrex(TREX) is the top producer of a high-end wood alternative for decks that comes from 95% recycled material, making it an eco-friendly housing play. The shares, at $105, trade for 43 times projected 2022 earnings.\nT. Rowe Price’s Spencer views Trex as worth the price, based on his view that it can generate sustainable annual revenue growth of 15% to 20%. Earnings are expected to climb by about 20% in 2022 and at a similar pace in the following years. “If you roll the clock forward three years, it doesn’t look as expensive,” he says.\nUpwork(UPWK), an online marketplace for freelance workers, is favored by Baillie Gifford’s Brodie, who says it offers a play on the greater acceptance of freelancers by businesses.\nThe shares, recently around $44, aren’t cheap. Upwork is valued at $5.7 billion, or more than 10 times this year’s projected sales of nearly $500 million. It operates at a slight loss.\nThe investment case is about rapid sales growth leading to ample earnings. Sales are expected to rise by 30%-plus this year and 25% for 2022.\n“Freelancers are more accepted by small to midsize business, but they’ve been frowned on by the HR departments at large businesses,” Brodie says. Upwork aims to change that perception by vetting its freelancers and by offering thousands of skill sets. “Upwork could become a trusted partner for an increasing number of enterprise-grade partners,” he says.","news_type":1},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897041026,"gmtCreate":1628864727165,"gmtModify":1631889843301,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897041026","repostId":"2159291893","repostType":4,"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898596050,"gmtCreate":1628507678770,"gmtModify":1631889843306,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/898596050","repostId":"2158443095","repostType":4,"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898598596,"gmtCreate":1628507655715,"gmtModify":1631889843308,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/898598596","repostId":"2158091443","repostType":4,"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891820909,"gmtCreate":1628380233101,"gmtModify":1631889843315,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/891820909","repostId":"1139912651","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899102008,"gmtCreate":1628166308404,"gmtModify":1631892364929,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899102008","repostId":"2157015435","repostType":4,"isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":885675824,"gmtCreate":1631792999268,"gmtModify":1631889843280,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/885675824","repostId":"2167351025","repostType":4,"isVote":1,"tweetType":1,"viewCount":770,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":883977110,"gmtCreate":1631199093330,"gmtModify":1631889843287,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"woww","listText":"woww","text":"woww","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883977110","repostId":"1171758120","repostType":4,"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898596050,"gmtCreate":1628507678770,"gmtModify":1631889843306,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/898596050","repostId":"2158443095","repostType":4,"isVote":1,"tweetType":1,"viewCount":272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897041026,"gmtCreate":1628864727165,"gmtModify":1631889843301,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897041026","repostId":"2159291893","repostType":4,"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":606667471,"gmtCreate":1638873538560,"gmtModify":1638873668908,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606667471","repostId":"1149974752","repostType":4,"repost":{"id":"1149974752","kind":"news","pubTimestamp":1638873109,"share":"https://www.laohu8.com/m/news/1149974752?lang=&edition=full","pubTime":"2021-12-07 18:31","market":"us","language":"en","title":"60 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1149974752","media":"Benzinga","summary":"Gainers\n\nInsignia Systems, Inc. shares jumped 200.4% to close at $15.05 on Monday after the company ","content":"<p><b>Gainers</b></p>\n<ul>\n <li><b>Insignia Systems, Inc.</b>&nbsp;shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.</li>\n <li><b>Del Taco Restaurants, Inc.</b>&nbsp;shares climbed 66.1% to close at $12.51 on Monday.</li>\n <li><b>Jack In The Box Inc</b>&nbsp;agreed to acquire Del Taco Restaurants for $12.51 per share in cash in a deal valued at about $575 million.</li>\n <li><b>Cumberland Pharmaceuticals Inc.</b>&nbsp;rose 51.2% to settle at $6.94 on above-average volume.</li>\n <li><b>Adicet Bio, Inc.</b>&nbsp;shares gained 38.5% to close at $13.57 after the company announced interim data from its dose escalation Phase 1 study evaluating the safety and tolerability of ADI-001.</li>\n <li><b>Advanced Human Imaging Limited</b>&nbsp;surged 30.9% to settle at $6.02.</li>\n <li><b>eFFECTOR Therapeutics, Inc.</b>&nbsp;gained 29.1% to close at $7.37.</li>\n <li><b>Cloopen Group Holding Limited</b>&nbsp;climbed 27% to settle at $3.43.</li>\n <li><b>Edgewise Therapeutics, Inc.</b>&nbsp;gained 22.8% to close at $18.42.</li>\n <li><b>GH Research PLC</b>&nbsp;gained 21.9% to close at $23.47 after the company reported better-than-expected Q3 EPS results.</li>\n <li><b>IN8bio, Inc.</b>&nbsp;rose 21.4% to close at $6.80. IN8bio, last month, named Trishna Goswami, M.D. as Chief Medical Officer.</li>\n <li><b>Liberty TripAdvisor Holdings, Inc.</b>&nbsp;gained 21.1% to close at $2.47.</li>\n <li><b>Progenity, Inc.</b>&nbsp;rose 19.5% to close at $2.82.</li>\n <li><b>Vasta Platform Limited</b>&nbsp;gained 18.8% to settle at $2.91.</li>\n <li><b>Xiaobai Maimai Inc.</b>&nbsp;rose 18% to close at $2.69.</li>\n <li><b>Atreca, Inc.</b>&nbsp;climbed 17.8% to settle at $3.38.</li>\n <li><b>Priority Technology Holdings, Inc.</b>&nbsp;rose 17.3% to close at $7.13.</li>\n <li><b>GCP Applied Technologies Inc.</b>&nbsp;gained 17.1% to close at $31.64. Saint-Gobain announced plans to buy GCP Applied Technologies in a deal valued at around $2.3 billion.</li>\n <li><b>FG Financial Group, Inc.</b>&nbsp;jumped 16.6% to settle at $3.79 as the company said its SPAC Platform partner, Aldel Financial has completed their previously announced business combination with Hagerty.</li>\n <li><b>Byrna Technologies Inc.</b>&nbsp;gained 16% to close at $15.16 after the company issued Q4 sales guidance above estimates and announced a $30 million buyback.</li>\n <li><b>Quoin Pharmaceuticals, Ltd.</b>&nbsp;rose 15.8% to close at $3.74.</li>\n <li><b>Kubient, Inc.</b>&nbsp;climbed 15.8% to close at $2.8250. Kubient, last month, posted a Q3 loss of $0.16 per share.</li>\n <li><b>KLX Energy Services Holdings, Inc.</b>&nbsp;gained 15.7% to settle at $3.57.</li>\n <li><b>North European Oil Royalty Trust</b>&nbsp;rose 14.8% to close at $9.86.</li>\n <li><b>Vicinity Motor Corp.</b>&nbsp;climbed 14.8% to close at $3.96.</li>\n <li><b>Offerpad Solutions Inc.</b>&nbsp;rose 14.8% to settle at $7.38.</li>\n <li><b>Sonendo, Inc.</b>&nbsp;gained 14.7% to close at $9.50.</li>\n <li><b>Twin Vee Powercats Co.</b>&nbsp;rose 13.8% to settle at $3.30.</li>\n <li><b>Recruiter.com Group, Inc.</b>&nbsp;rose 9.8% to close at $3.14.</li>\n <li><b>CF Acquisition Corp. VI</b>&nbsp;rose 6.7% to close at $12.70 on continued strength following the SPACs announcement of a merger with Rumble.</li>\n</ul>\n<p><b>Losers</b></p>\n<ul>\n <li><b>Bolt Biotherapeutics, Inc.</b>&nbsp;shares fell 55.8% to settle at $4.64 on Monday. Bolt Biotherapeutics announced the presentation of interim clinical data from its Phase 1/2 study of BDC-1001.</li>\n <li><b>Alset EHome International Inc.</b>&nbsp;shares dropped 41.7% to close at $0.6302 on Monday after the company priced its $30 million underwritten public offering.</li>\n <li><b>Reata Pharmaceuticals, Inc.</b>&nbsp;fell 37.8% to close at $48.92. Traders circulated the FDA briefing document saying 'FDA review team does not believe the submitted data demonstrate that bardoxolone is effective in slowing the loss of kidney function in patients with AS...'</li>\n <li><b>Aeglea BioTherapeutics, Inc.</b>&nbsp;declined 36.5% to close at $3.81 after the company announced data from the Phase 3 study of pegzilarginase in Arginase 1 Deficiency (ARG1-D) patients aged two years and older. ARG1-D is a rare disease characterized by high levels of the amino acid arginine. The disease manifestations include spasticity, developmental delay, intellectual disability, and seizures.</li>\n <li><b>MiNK Therapeutics, Inc.</b>&nbsp;fell 34.6% to settle at $6.85.</li>\n <li><b>Nam Tai Property Inc.</b>&nbsp;fell 29.8% to close at $10.00. Nam Tai Property confirmed results of special meeting of shareholders.</li>\n <li><b>Adagio Therapeutics, Inc.</b>&nbsp;dipped 29% to close at $32.53.</li>\n <li><b>Finch Therapeutics Group, Inc.</b>&nbsp;fell 28.4% to close at $10.97.</li>\n <li><b>Elevation Oncology, Inc.</b>&nbsp;fell 28.3% to close at $4.35.</li>\n <li><b>Arqit Quantum Inc.</b>&nbsp;dipped 27.6% to settle at $27.07 amid a rotation out of the space as well as a rise in treasury yields, which has pressured growth names.</li>\n <li><b>Creative Medical Technology Holdings, Inc.</b>&nbsp;dropped 27.4% to close at $1.62.</li>\n <li><b>Beyond Air, Inc.</b>&nbsp;fell 23.4% to close at $10.36.</li>\n <li><b>IsoPlexis Corporation</b>&nbsp;fell 22.7% to settle at $8.02.</li>\n <li><b>Pyxis Oncology, Inc.</b>&nbsp;dipped 20.9% to close at $9.64.</li>\n <li><b>POINT Biopharma Global Inc.</b>&nbsp;fell 20.9% to settle at $6.22.</li>\n <li><b>Imago BioSciences, Inc.</b>&nbsp;fell 20.6% to close at $16.22. Imago BioSciences, last month, posted a Q3 loss of $0.44 per share.</li>\n <li><b>OceanPal Inc.</b>&nbsp;fell 19.5% to settle at $3.30. OceanPal recently entered into a time charter trip contract for its Panamax dry bulk vessel, the m/v Calipso, a 73,691 dwt vessel built in 2005, at a gross charter rate of $18,750 per day, for about 15-20 days.</li>\n <li><b>BioNTech SE</b>&nbsp;dropped 18.7% to close at $279.83 as vaccine names pulled back after gaining in late November amid omicron concerns.</li>\n <li><b>Onion Global Limited</b>&nbsp;dipped 18% to settle at $3.18.</li>\n <li><b>uCloudlink Group Inc.</b>&nbsp;fell 17.5% to close at $2.31.</li>\n <li><b>Vaxxinity, Inc.</b>&nbsp;fell 17% to close at $7.32. B of A Securities initiated coverage on Vaxxinity with a Buy rating and announced a price target of $21.</li>\n <li><b>Entrada Therapeutics, Inc.</b>&nbsp;dropped 16.7% to settle at $22.26.</li>\n <li><b>Enjoy Technology, Inc.</b>&nbsp;declined 16.2% to close at $4.51.</li>\n <li><b>Bird Global, Inc.</b>&nbsp;fell 13.7% to close at $6.87.</li>\n <li><b>Moderna, Inc.</b>&nbsp;dipped 13.5% to close at $265.33. Moderna President Stephen Hoge said there’s a “real risk” that existing COVID-19 vaccines will be less effective against omicron, reported Bloomberg. In contrast, U.S. medical adviser Anthony Fauci said the variant’s severity might be limited.</li>\n <li><b>Kazia Therapeutics Limited</b>&nbsp;fell 13.4% to clsoe at $7.92.&nbsp;Kazia Therapeutics, last week announced&nbsp;final data from a Phase2 study&nbsp;of paxalisib as first-line therapy in patients with glioblastoma.</li>\n <li><b>AEye, Inc.</b>&nbsp;fell 12.7% to close at $4.60.</li>\n <li><b>Zscaler, Inc.</b>&nbsp;fell 12.4% to close at $274.36. Daiwa Capital downgraded Zscaler from Neutral to Underperform and announced a $286 price target.</li>\n <li><b>Erasca, Inc.</b>&nbsp;dropped 11.5% to close at $12.51. Erasca, last month, posted a Q3 loss of $0.46 per share.</li>\n <li><b>BuzzFeed</b>&nbsp;fell 11% to close at $8.56. The company has called itself \"the first publicly traded purely digital media company.\" Buzzfeed started trading on the Nasdaq on Monday.</li>\n <li><b>AST SpaceMobile, Inc.</b>&nbsp;shares fell 8.9% to close at $8.42. AST SpaceMobile, last month, posted Q3 EPS of $0.07 on sales of $2.45 million.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>60 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n60 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 18:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24474142/60-biggest-movers-from-yesterday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nInsignia Systems, Inc. shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24474142/60-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","BZFD":"Buzzfeed"},"source_url":"https://www.benzinga.com/news/21/12/24474142/60-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149974752","content_text":"Gainers\n\nInsignia Systems, Inc. shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore strategic options to maximize shareholder value, including potential merger or acquisition.\nDel Taco Restaurants, Inc. shares climbed 66.1% to close at $12.51 on Monday.\nJack In The Box Inc agreed to acquire Del Taco Restaurants for $12.51 per share in cash in a deal valued at about $575 million.\nCumberland Pharmaceuticals Inc. rose 51.2% to settle at $6.94 on above-average volume.\nAdicet Bio, Inc. shares gained 38.5% to close at $13.57 after the company announced interim data from its dose escalation Phase 1 study evaluating the safety and tolerability of ADI-001.\nAdvanced Human Imaging Limited surged 30.9% to settle at $6.02.\neFFECTOR Therapeutics, Inc. gained 29.1% to close at $7.37.\nCloopen Group Holding Limited climbed 27% to settle at $3.43.\nEdgewise Therapeutics, Inc. gained 22.8% to close at $18.42.\nGH Research PLC gained 21.9% to close at $23.47 after the company reported better-than-expected Q3 EPS results.\nIN8bio, Inc. rose 21.4% to close at $6.80. IN8bio, last month, named Trishna Goswami, M.D. as Chief Medical Officer.\nLiberty TripAdvisor Holdings, Inc. gained 21.1% to close at $2.47.\nProgenity, Inc. rose 19.5% to close at $2.82.\nVasta Platform Limited gained 18.8% to settle at $2.91.\nXiaobai Maimai Inc. rose 18% to close at $2.69.\nAtreca, Inc. climbed 17.8% to settle at $3.38.\nPriority Technology Holdings, Inc. rose 17.3% to close at $7.13.\nGCP Applied Technologies Inc. gained 17.1% to close at $31.64. Saint-Gobain announced plans to buy GCP Applied Technologies in a deal valued at around $2.3 billion.\nFG Financial Group, Inc. jumped 16.6% to settle at $3.79 as the company said its SPAC Platform partner, Aldel Financial has completed their previously announced business combination with Hagerty.\nByrna Technologies Inc. gained 16% to close at $15.16 after the company issued Q4 sales guidance above estimates and announced a $30 million buyback.\nQuoin Pharmaceuticals, Ltd. rose 15.8% to close at $3.74.\nKubient, Inc. climbed 15.8% to close at $2.8250. Kubient, last month, posted a Q3 loss of $0.16 per share.\nKLX Energy Services Holdings, Inc. gained 15.7% to settle at $3.57.\nNorth European Oil Royalty Trust rose 14.8% to close at $9.86.\nVicinity Motor Corp. climbed 14.8% to close at $3.96.\nOfferpad Solutions Inc. rose 14.8% to settle at $7.38.\nSonendo, Inc. gained 14.7% to close at $9.50.\nTwin Vee Powercats Co. rose 13.8% to settle at $3.30.\nRecruiter.com Group, Inc. rose 9.8% to close at $3.14.\nCF Acquisition Corp. VI rose 6.7% to close at $12.70 on continued strength following the SPACs announcement of a merger with Rumble.\n\nLosers\n\nBolt Biotherapeutics, Inc. shares fell 55.8% to settle at $4.64 on Monday. Bolt Biotherapeutics announced the presentation of interim clinical data from its Phase 1/2 study of BDC-1001.\nAlset EHome International Inc. shares dropped 41.7% to close at $0.6302 on Monday after the company priced its $30 million underwritten public offering.\nReata Pharmaceuticals, Inc. fell 37.8% to close at $48.92. Traders circulated the FDA briefing document saying 'FDA review team does not believe the submitted data demonstrate that bardoxolone is effective in slowing the loss of kidney function in patients with AS...'\nAeglea BioTherapeutics, Inc. declined 36.5% to close at $3.81 after the company announced data from the Phase 3 study of pegzilarginase in Arginase 1 Deficiency (ARG1-D) patients aged two years and older. ARG1-D is a rare disease characterized by high levels of the amino acid arginine. The disease manifestations include spasticity, developmental delay, intellectual disability, and seizures.\nMiNK Therapeutics, Inc. fell 34.6% to settle at $6.85.\nNam Tai Property Inc. fell 29.8% to close at $10.00. Nam Tai Property confirmed results of special meeting of shareholders.\nAdagio Therapeutics, Inc. dipped 29% to close at $32.53.\nFinch Therapeutics Group, Inc. fell 28.4% to close at $10.97.\nElevation Oncology, Inc. fell 28.3% to close at $4.35.\nArqit Quantum Inc. dipped 27.6% to settle at $27.07 amid a rotation out of the space as well as a rise in treasury yields, which has pressured growth names.\nCreative Medical Technology Holdings, Inc. dropped 27.4% to close at $1.62.\nBeyond Air, Inc. fell 23.4% to close at $10.36.\nIsoPlexis Corporation fell 22.7% to settle at $8.02.\nPyxis Oncology, Inc. dipped 20.9% to close at $9.64.\nPOINT Biopharma Global Inc. fell 20.9% to settle at $6.22.\nImago BioSciences, Inc. fell 20.6% to close at $16.22. Imago BioSciences, last month, posted a Q3 loss of $0.44 per share.\nOceanPal Inc. fell 19.5% to settle at $3.30. OceanPal recently entered into a time charter trip contract for its Panamax dry bulk vessel, the m/v Calipso, a 73,691 dwt vessel built in 2005, at a gross charter rate of $18,750 per day, for about 15-20 days.\nBioNTech SE dropped 18.7% to close at $279.83 as vaccine names pulled back after gaining in late November amid omicron concerns.\nOnion Global Limited dipped 18% to settle at $3.18.\nuCloudlink Group Inc. fell 17.5% to close at $2.31.\nVaxxinity, Inc. fell 17% to close at $7.32. B of A Securities initiated coverage on Vaxxinity with a Buy rating and announced a price target of $21.\nEntrada Therapeutics, Inc. dropped 16.7% to settle at $22.26.\nEnjoy Technology, Inc. declined 16.2% to close at $4.51.\nBird Global, Inc. fell 13.7% to close at $6.87.\nModerna, Inc. dipped 13.5% to close at $265.33. Moderna President Stephen Hoge said there’s a “real risk” that existing COVID-19 vaccines will be less effective against omicron, reported Bloomberg. In contrast, U.S. medical adviser Anthony Fauci said the variant’s severity might be limited.\nKazia Therapeutics Limited fell 13.4% to clsoe at $7.92. Kazia Therapeutics, last week announced final data from a Phase2 study of paxalisib as first-line therapy in patients with glioblastoma.\nAEye, Inc. fell 12.7% to close at $4.60.\nZscaler, Inc. fell 12.4% to close at $274.36. Daiwa Capital downgraded Zscaler from Neutral to Underperform and announced a $286 price target.\nErasca, Inc. dropped 11.5% to close at $12.51. Erasca, last month, posted a Q3 loss of $0.46 per share.\nBuzzFeed fell 11% to close at $8.56. The company has called itself \"the first publicly traded purely digital media company.\" Buzzfeed started trading on the Nasdaq on Monday.\nAST SpaceMobile, Inc. shares fell 8.9% to close at $8.42. AST SpaceMobile, last month, posted Q3 EPS of $0.07 on sales of $2.45 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878919440,"gmtCreate":1637136458239,"gmtModify":1637136458484,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"🤑🤑","listText":"🤑🤑","text":"🤑🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878919440","repostId":"1153997204","repostType":4,"isVote":1,"tweetType":1,"viewCount":1125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861889543,"gmtCreate":1632482046782,"gmtModify":1632719314508,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861889543","repostId":"1147407851","repostType":4,"repost":{"id":"1147407851","kind":"news","pubTimestamp":1632476902,"share":"https://www.laohu8.com/m/news/1147407851?lang=&edition=full","pubTime":"2021-09-24 17:48","market":"us","language":"en","title":"EU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1147407851","media":"zerohedge","summary":"In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing","content":"<p>In keeping with their more cautious approach toward approving COVID jabs,<b>EU regulators are preparing to make their own decisions about whether to approve booster shots with Pfizer jab</b>s - but not until early October,Reuters reportedThursday.</p>\n<p>Reuters pointed out that<b>the upcoming review of the Pfizer booster jab would mark the European regulators' first decision about doling out booster jabs</b>in the EU.</p>\n<p>In an opinion issued earlier this month that was republished by the EMA,<b>the European Center for Disease Prevention and Control</b>- or ECDC, one of several regulators that comprises the EU's highest-level of health regulators -<b>said there was no \"urgent need\" to administer booster doses</b>to fully vaccinated individuals in the general population.</p>\n<p>But it also noted that additional doses are already being considered and doled out to the elderly, the immuno-compromised, and whatever</p>\n<p>Regardless of whatever the bloc decides,<b>it has already signed recent deals with Pfizer and BioNTech for 2.4 billion more mRNA jabs.</b></p>\n<p>The latest contract covers the supply of at least 900MM shots, which will only be needed if the EU goes ahead with expansive booster jab program and offers them to all adults 16 and up. . Over 70% of the EU's adult population has already been fully vaccinated, and the bloc has secured an ample supply of vaccines from several manufacturers.</p>\n<p>Still, as the delta wave continues to create problems for politicians around the world, they might grow increasingly desperate to force the population to get 3, 4 or even 5 jabs - despite the fact that The ECDC has said crucial data on the need and safety of boosters hasn't yet been gleaned from the studies unfurling around the world rfhr n in part because it is not yet fully clear how long vaccines protect against the virus.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU Will Wait To Decide On Pfizer Boosters Due To Shortage Of Safety Data\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 17:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/geopolitical/eu-will-wait-decide-pfizer-boosters-due-shortage-safety-data?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing to make their own decisions about whether to approve booster shots with Pfizer jabs - but not until...</p>\n\n<a href=\"https://www.zerohedge.com/geopolitical/eu-will-wait-decide-pfizer-boosters-due-shortage-safety-data?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.zerohedge.com/geopolitical/eu-will-wait-decide-pfizer-boosters-due-shortage-safety-data?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147407851","content_text":"In keeping with their more cautious approach toward approving COVID jabs,EU regulators are preparing to make their own decisions about whether to approve booster shots with Pfizer jabs - but not until early October,Reuters reportedThursday.\nReuters pointed out thatthe upcoming review of the Pfizer booster jab would mark the European regulators' first decision about doling out booster jabsin the EU.\nIn an opinion issued earlier this month that was republished by the EMA,the European Center for Disease Prevention and Control- or ECDC, one of several regulators that comprises the EU's highest-level of health regulators -said there was no \"urgent need\" to administer booster dosesto fully vaccinated individuals in the general population.\nBut it also noted that additional doses are already being considered and doled out to the elderly, the immuno-compromised, and whatever\nRegardless of whatever the bloc decides,it has already signed recent deals with Pfizer and BioNTech for 2.4 billion more mRNA jabs.\nThe latest contract covers the supply of at least 900MM shots, which will only be needed if the EU goes ahead with expansive booster jab program and offers them to all adults 16 and up. . Over 70% of the EU's adult population has already been fully vaccinated, and the bloc has secured an ample supply of vaccines from several manufacturers.\nStill, as the delta wave continues to create problems for politicians around the world, they might grow increasingly desperate to force the population to get 3, 4 or even 5 jabs - despite the fact that The ECDC has said crucial data on the need and safety of boosters hasn't yet been gleaned from the studies unfurling around the world rfhr n in part because it is not yet fully clear how long vaccines protect against the virus.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":813515941,"gmtCreate":1630213493183,"gmtModify":1704957130540,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Hmm🤔","listText":"Hmm🤔","text":"Hmm🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/813515941","repostId":"2162358024","repostType":4,"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898598596,"gmtCreate":1628507655715,"gmtModify":1631889843308,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/898598596","repostId":"2158091443","repostType":4,"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891820909,"gmtCreate":1628380233101,"gmtModify":1631889843315,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/891820909","repostId":"1139912651","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899102008,"gmtCreate":1628166308404,"gmtModify":1631892364929,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/899102008","repostId":"2157015435","repostType":4,"isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":821430648,"gmtCreate":1633769450905,"gmtModify":1633769450905,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"&nbsp;okay","listText":"&nbsp;okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/821430648","repostId":"1135231383","repostType":4,"repost":{"id":"1135231383","kind":"news","pubTimestamp":1633746259,"share":"https://www.laohu8.com/m/news/1135231383?lang=&edition=full","pubTime":"2021-10-09 10:24","market":"us","language":"en","title":"NVIDIA acquires formal verification firm Oski Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1135231383","media":"seekingalpha","summary":"Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nF","content":"<ul>\n <li>Visual computing company NVIDIA(NASDAQ:NVDA)has&nbsp;acquired&nbsp;formal verification firm Oski Technology.</li>\n <li>Founded in 2005, Oski specializes in formal verification methods and has been a long-standing partner to NVIDIA for more than 10 years. The company operates offices in San Jose, Budapest and Gurgaon.</li>\n <li>As NVIDIA's products have grown in complexity and scope, now spanning markets from gaming and data center computing to networking and autonomous vehicles, the importance of designing perfect first silicon has never been higher. And new autonomous machine applications where safety is the highest goal make verification vital.</li>\n <li>The Oski&nbsp;acquisition will enable NVIDIA to significantly increase its investment in formal verification strategies to achieve that goal.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NVIDIA acquires formal verification firm Oski Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNVIDIA acquires formal verification firm Oski Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nFounded in 2005, Oski specializes in formal verification methods and has been a long-standing partner...</p>\n\n<a href=\"https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://seekingalpha.com/news/3750986-nvidia-acquires-formal-verification-firm-oski-technology","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135231383","content_text":"Visual computing company NVIDIA(NASDAQ:NVDA)has acquired formal verification firm Oski Technology.\nFounded in 2005, Oski specializes in formal verification methods and has been a long-standing partner to NVIDIA for more than 10 years. The company operates offices in San Jose, Budapest and Gurgaon.\nAs NVIDIA's products have grown in complexity and scope, now spanning markets from gaming and data center computing to networking and autonomous vehicles, the importance of designing perfect first silicon has never been higher. And new autonomous machine applications where safety is the highest goal make verification vital.\nThe Oski acquisition will enable NVIDIA to significantly increase its investment in formal verification strategies to achieve that goal.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":833715618,"gmtCreate":1629262714834,"gmtModify":1631889843295,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Woww","listText":"Woww","text":"Woww","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/833715618","repostId":"2160781981","repostType":4,"isVote":1,"tweetType":1,"viewCount":337,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":830364522,"gmtCreate":1629014165466,"gmtModify":1631889843297,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/830364522","repostId":"1127633167","repostType":4,"repost":{"id":"1127633167","kind":"news","pubTimestamp":1628997765,"share":"https://www.laohu8.com/m/news/1127633167?lang=&edition=full","pubTime":"2021-08-15 11:22","market":"us","language":"en","title":"These 10 Standout Stocks Could Be the Next Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=1127633167","media":"Barrons","summary":"One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors loo","content":"<p>One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of generating double-digit compound growth in revenue and earnings—preferably both—for years to come.</p>\n<p>The idea is that stock prices should compound in line with revenue and profits, enabling investors to generate high returns over a holding period of five to 10 years. The ultimate goal is to find the elusive “10 bagger”—a stock&nbsp;that returns 10 times what you paid for it.</p>\n<p>Wall Street analyst notes and client letters from investment pros are replete with compounder references. Many of the next generation of value managers, identified&nbsp;in a&nbsp;<i>Barron’s</i>&nbsp;cover story in May, are seeking such shares, rather than the traditional value fare of cheap stocks.</p>\n<p>Their search has become more challenging, because buyers are paying lofty prices for high-growth stories. Really big winners are scarce. Only about 35 companies in each of a long series of 10-year periods have compounded their stock prices at 20% or more annually, resulting in at least a sixfold increase, according to Durable Capital Partners.</p>\n<p>Many investors are happy to stick with large, well-known compounders, such as&nbsp;Alphabet(ticker: GOOGL),Mastercard(MA),UnitedHealth Group(UNH), and&nbsp;Eli Lilly(LLY).</p>\n<p><i>Barron’s</i>&nbsp;sought to identify smaller candidates. We talked to investment managers and came up with an eclectic list of 10 stocks, most with market values under $10 billion. Here are the selections, in alphabetical order:</p>\n<p>Strong and Steady Wins the RaceHere are 10 stocks that growth investors have identified as being able to generate consistently high growth in revenues or profits for many years.</p>\n<table>\n <thead>\n  <tr>\n   <th>Company / Ticker</th>\n   <th>Recent Price</th>\n   <th>YTD Change</th>\n   <th>2021E P/E</th>\n   <th>2021E Price/Sales</th>\n   <th>2022E P/E</th>\n   <th>2022E Price/Sales</th>\n   <th>LT Growth Rate*</th>\n   <th>Market Value (bil)</th>\n   <th>Comment</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Amedysis / AMED</td>\n   <td>$185.15</td>\n   <td>-37%</td>\n   <td>30.2</td>\n   <td>2.7</td>\n   <td>27.7</td>\n   <td>2.4</td>\n   <td>10.5%</td>\n   <td>$6.3</td>\n   <td>Leader in home health care</td>\n  </tr>\n  <tr>\n   <td>Amyris / AMRS</td>\n   <td>13.64</td>\n   <td>121</td>\n   <td>NM</td>\n   <td>10.4</td>\n   <td>NM</td>\n   <td>9.7</td>\n   <td>NA</td>\n   <td>4.1</td>\n   <td>Leading company in synthetic biology</td>\n  </tr>\n  <tr>\n   <td>Booz Allen Hamilton Holding / BAH</td>\n   <td>81.73</td>\n   <td>-6</td>\n   <td>19.4</td>\n   <td>1.3</td>\n   <td>17.7</td>\n   <td>1.2</td>\n   <td>8.6</td>\n   <td>11.0</td>\n   <td>Defense-department consultant</td>\n  </tr>\n  <tr>\n   <td>J.B. Hunt Transport Services / JBHT</td>\n   <td>172.76</td>\n   <td>26</td>\n   <td>25.8</td>\n   <td>1.5</td>\n   <td>22.2</td>\n   <td>1.4</td>\n   <td>18.4</td>\n   <td>18.2</td>\n   <td>Strong in intermodal freight</td>\n  </tr>\n  <tr>\n   <td>Marriott Vacations Worldwide / VAC</td>\n   <td>147.15</td>\n   <td>7</td>\n   <td>40.9</td>\n   <td>1.6</td>\n   <td>15.7</td>\n   <td>1.4</td>\n   <td>NA</td>\n   <td>6.3</td>\n   <td>Top company in vacation timeshares</td>\n  </tr>\n  <tr>\n   <td>SiteOne Landscape Supply / SITE</td>\n   <td>197.10</td>\n   <td>24</td>\n   <td>45.7</td>\n   <td>2.6</td>\n   <td>43.5</td>\n   <td>2.5</td>\n   <td>19.3</td>\n   <td>8.8</td>\n   <td>Big supplier of landscaping supplies</td>\n  </tr>\n  <tr>\n   <td>Staar Surgical / STAA</td>\n   <td>138.19</td>\n   <td>74</td>\n   <td>192.3</td>\n   <td>28.6</td>\n   <td>140.8</td>\n   <td>22.5</td>\n   <td>30.0</td>\n   <td>6.6</td>\n   <td>Maker of implantable lens for myopia</td>\n  </tr>\n  <tr>\n   <td>Stitch Fix / SFIX</td>\n   <td>44.38</td>\n   <td>-24</td>\n   <td>NM</td>\n   <td>1.9</td>\n   <td>1890.3</td>\n   <td>1.7</td>\n   <td>30.0</td>\n   <td>4.8</td>\n   <td>Data-driven subscription clothing firm</td>\n  </tr>\n  <tr>\n   <td>Trex / TREX</td>\n   <td>105.94</td>\n   <td>27</td>\n   <td>51.9</td>\n   <td>10.5</td>\n   <td>43.6</td>\n   <td>9.3</td>\n   <td>18.8</td>\n   <td>12.2</td>\n   <td>Top maker of synthetic wood decking</td>\n  </tr>\n  <tr>\n   <td>Upwork / UPWK</td>\n   <td>44.31</td>\n   <td>28</td>\n   <td>NM</td>\n   <td>11.4</td>\n   <td>556.8</td>\n   <td>9.2</td>\n   <td>NA</td>\n   <td>5.7</td>\n   <td>Online clearinghouse for free-lancers</td>\n  </tr>\n </tbody>\n</table>\n<p>E=Estimate. BAH estimates are for fiscal years ending March 2022 and March 23. SFIX estimates are for fiscal years ending July 2022 and July 2023. NM=Not Meaningful. NA=Not Available. *The annual EPS growth the company can sustain over the next 3-5 years.</p>\n<p>Source: FactSet</p>\n<p>Amedisys(AMED), a provider of home healthcare and hospice services, has a national footprint in a still-fragmented business.</p>\n<p>“There is going to be massive consolidation of the industry” predicts Dan Cole, a manager of the Columbia Small-Cap Growth fund. “Healthcare is moving to the home.”</p>\n<p>Amedisys stock is up more than tenfold in the past decade. But the shares, around $185, are off nearly 30% after the company recently cut 2021 financial guidance, citing Covid-related staffing and cost issues, mostly in acquired hospice operations. The 2021 earnings estimate is now $6.13 a share, down from nearly $7. The stock trades for 30 times projected 2021 profits. Cole says that the company remains capable of generating 10% annual gains in earnings per share.</p>\n<p>Amyris(AMRS) is a leader in synthetic biology. It fans say its opportunity is to supplant, in an eco-friendly way, a range of products now made from petrochemicals, animals, and plants.</p>\n<p>Using genetically re-engineered yeast and sugar cane, Amyris produces such things as squalane, a high-end moisturizer formerly made from shark livers; vanillin, the flavoring for vanilla; and a no-calorie sweetener normally derived from plants. The stock trades around $13.</p>\n<p><i>Barron’s</i>&nbsp;wrote&nbsp;favorably on the company in July. Amyris sees sales reaching $2 billion by 2025, up from an estimated $400 million this year, driven by its consumer brands.</p>\n<p>“The world needs clean chemistry, and Amyris is the point on the spear to create it,” says Randy Baron, a portfolio manager at Pinnacle Associates, which owns Amyris shares. He thinks they could hit $75 by the end of 2022.</p>\n<p>Booz Allen Hamilton Holding(BAH) is an important consultant to the Defense Department and other agencies. The U.S. government accounted for 97% of its revenue in its latest fiscal year. Booz Allen has built robust ties to the government over the years by providing an array of services, like cybersecurity. Its stock trades around $81, for a 1.8% yield.</p>\n<p>“It has built a strong, partnership-like culture and has a long record of steady growth,” says Josh Spencer, manager of the T. Rowe Price New Horizons fund. He sees Booz Allen as capable of generating 9% to 10% annual growth in revenue and yearly gains of 15% to 16% in earnings, in line with its historical performance. The stock is off 20% from its peak of $100, amid concerns about more restrained military spending. Spencer sees the pullback as a buying opportunity, with the stock valued at less than 20 times earnings.</p>\n<p>J.B. Hunt Transport Services(JBHT) is a leader in intermodal freight, which involves the fuel-efficient movement of trucks over rail lines. It has been one of the most successful trucking companies. Its stock has risen 30-fold over the past 20 years, to a recent $173. “It has an incredible franchise,” says Henry Ellenbogen, chief investment officer at Durable Capital Partners and a member of the&nbsp;Barron’s Roundtable.</p>\n<p>J.B. Hunt’s relationship with the Burlington Northern Santa Fe railroad gives it a strong position in intermodal freight, he notes. J.B. Hunt also has a growing business taking over the trucking operations of smaller companies. And it is involved in digital freight brokerage—matching truckers with shipping customers.</p>\n<p>Ellenbogen says the stock is reasonable at 22 times estimated 2022 profits, given a mid-teens annual growth outlook for earnings.</p>\n<p>Marriott Vacations Worldwide(VAC) is one of the top companies in the timeshare industry. It has 700,000 owners, a resilient business model with significant revenue from fees, and more exposure than its peers to luxury properties in places including Hawaii and Orlando, Fla.</p>\n<p>“It has the best customer base, with the highest spending and an impeccable balance sheet,” says David Baron, a manager of the Baron Focused Growth fund. Marriott Vacations, whose shares recently were trading around $145, should reinstate its dividend later this year, he adds.</p>\n<p>The shares, Baron argues, are cheap at a 11% free-cash-flow yield, based on 2022 estimates. He says that the stock, little changed since 2018, could produce 20% annual returns for shareholders in the coming years.</p>\n<p>SiteOne Landscape Supply(SITE) is the country’s top supplier of landscaping products, with ample opportunity to expand, given that it has just a 13% market share in a highly fragmented industry.</p>\n<p></p>\n<p>“It’s growing organically and has lots of acquisition opportunities,” says Columbia’s Cole, who considers the company to be capable of 10% to 15% annual revenue growth.</p>\n<p>The stock, around $197, has a rich valuation, trading for 43 times projected 2022 earnings of $4.54 a share.</p>\n<p>Staar Surgical(STAA) has developed an implantable lens to correct myopia (nearsightedness). That addresses a potentially huge market, given the rising global incidence of that vision problem. The company expects the lens, which has been available in Europe and Asia for at least five years, to be on the U.S. market in the fourth quarter, pending Food and Drug Administration approval.</p>\n<p>“It could do substantial volumes,’’ says Doug Brodie, a global manager at Baillie Gifford. “It’s early in a journey and is largely devoid of competition.”</p>\n<p>Lenses for both eyes can be implanted in less than an hour, and they don’t involve the removal of the natural lenses. The wholesale cost in the U.S. could be around $1,000 per lens.</p>\n<p>At a recent $138, Staar shares are richly valued at more than 20 times projected 2022 sales and 140 times estimated 2022 earnings. But the market opportunity is enormous: Some five billion people worldwide could have myopia by 2050.</p>\n<p>Stitch Fix(SFIX) has developed a subscription service for clothing, shoes, and other accessories and boasts over four million customers.</p>\n<p>“This could be the Nordstrom of the future,” says Mario Cibelli, chief investment officer at Marathon Partners Equity Management, a Stitch Fix holder. “This a potentially huge market and nobody is addressing it in the same way.” Using a staff of 6,000 personal stylists and lots of data, Stitch Fix seeks to identify subscriber tastes to generate high satisfaction and limit returns on packages sent at intervals and determined by subscribers.</p>\n<p>Its shares, around $44, are down 60% from their level earlier in the year, on investors’ worries about potential churn and the business’s ultimate profitability.</p>\n<p>Yet Cibelli sees revenue growth of 20%-plus annually, opportunities outside its current U.S. and U.K. markets, and a potentially very profitable business in two to three years.</p>\n<p>Trex(TREX) is the top producer of a high-end wood alternative for decks that comes from 95% recycled material, making it an eco-friendly housing play. The shares, at $105, trade for 43 times projected 2022 earnings.</p>\n<p>T. Rowe Price’s Spencer views Trex as worth the price, based on his view that it can generate sustainable annual revenue growth of 15% to 20%. Earnings are expected to climb by about 20% in 2022 and at a similar pace in the following years. “If you roll the clock forward three years, it doesn’t look as expensive,” he says.</p>\n<p>Upwork(UPWK), an online marketplace for freelance workers, is favored by Baillie Gifford’s Brodie, who says it offers a play on the greater acceptance of freelancers by businesses.</p>\n<p>The shares, recently around $44, aren’t cheap. Upwork is valued at $5.7 billion, or more than 10 times this year’s projected sales of nearly $500 million. It operates at a slight loss.</p>\n<p>The investment case is about rapid sales growth leading to ample earnings. Sales are expected to rise by 30%-plus this year and 25% for 2022.</p>\n<p>“Freelancers are more accepted by small to midsize business, but they’ve been frowned on by the HR departments at large businesses,” Brodie says. Upwork aims to change that perception by vetting its freelancers and by offering thousands of skill sets. “Upwork could become a trusted partner for an increasing number of enterprise-grade partners,” he says.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 10 Standout Stocks Could Be the Next Amazon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 10 Standout Stocks Could Be the Next Amazon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-15 11:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of ...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMED":"阿米斯医疗","VAC":"万豪度假环球","TREX":"Trex Co Inc","SFIX":"Stitch Fix Inc.","BAH":"博思艾伦咨询公司","SITE":"SiteOne Landscape Supply, Inc.","AMRS":"阿米瑞斯","STAA":"STAAR Surgical Company","UPWK":"Upwork Inc.","JBHT":"JB Hunt运输服务"},"source_url":"https://www.barrons.com/articles/stocks-potential-compounder-growth-51628888840?mod=hp_LEADSUPP_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127633167","content_text":"One of the most popular buzzwords in investing today is “compounders.” Growth-oriented investors looking for the next Amazon.com, Costco Wholesale, Nike, or Visa seek to identify companies capable of generating double-digit compound growth in revenue and earnings—preferably both—for years to come.\nThe idea is that stock prices should compound in line with revenue and profits, enabling investors to generate high returns over a holding period of five to 10 years. The ultimate goal is to find the elusive “10 bagger”—a stock that returns 10 times what you paid for it.\nWall Street analyst notes and client letters from investment pros are replete with compounder references. Many of the next generation of value managers, identified in a Barron’s cover story in May, are seeking such shares, rather than the traditional value fare of cheap stocks.\nTheir search has become more challenging, because buyers are paying lofty prices for high-growth stories. Really big winners are scarce. Only about 35 companies in each of a long series of 10-year periods have compounded their stock prices at 20% or more annually, resulting in at least a sixfold increase, according to Durable Capital Partners.\nMany investors are happy to stick with large, well-known compounders, such as Alphabet(ticker: GOOGL),Mastercard(MA),UnitedHealth Group(UNH), and Eli Lilly(LLY).\nBarron’s sought to identify smaller candidates. We talked to investment managers and came up with an eclectic list of 10 stocks, most with market values under $10 billion. Here are the selections, in alphabetical order:\nStrong and Steady Wins the RaceHere are 10 stocks that growth investors have identified as being able to generate consistently high growth in revenues or profits for many years.\n\n\n\nCompany / Ticker\nRecent Price\nYTD Change\n2021E P/E\n2021E Price/Sales\n2022E P/E\n2022E Price/Sales\nLT Growth Rate*\nMarket Value (bil)\nComment\n\n\n\n\nAmedysis / AMED\n$185.15\n-37%\n30.2\n2.7\n27.7\n2.4\n10.5%\n$6.3\nLeader in home health care\n\n\nAmyris / AMRS\n13.64\n121\nNM\n10.4\nNM\n9.7\nNA\n4.1\nLeading company in synthetic biology\n\n\nBooz Allen Hamilton Holding / BAH\n81.73\n-6\n19.4\n1.3\n17.7\n1.2\n8.6\n11.0\nDefense-department consultant\n\n\nJ.B. Hunt Transport Services / JBHT\n172.76\n26\n25.8\n1.5\n22.2\n1.4\n18.4\n18.2\nStrong in intermodal freight\n\n\nMarriott Vacations Worldwide / VAC\n147.15\n7\n40.9\n1.6\n15.7\n1.4\nNA\n6.3\nTop company in vacation timeshares\n\n\nSiteOne Landscape Supply / SITE\n197.10\n24\n45.7\n2.6\n43.5\n2.5\n19.3\n8.8\nBig supplier of landscaping supplies\n\n\nStaar Surgical / STAA\n138.19\n74\n192.3\n28.6\n140.8\n22.5\n30.0\n6.6\nMaker of implantable lens for myopia\n\n\nStitch Fix / SFIX\n44.38\n-24\nNM\n1.9\n1890.3\n1.7\n30.0\n4.8\nData-driven subscription clothing firm\n\n\nTrex / TREX\n105.94\n27\n51.9\n10.5\n43.6\n9.3\n18.8\n12.2\nTop maker of synthetic wood decking\n\n\nUpwork / UPWK\n44.31\n28\nNM\n11.4\n556.8\n9.2\nNA\n5.7\nOnline clearinghouse for free-lancers\n\n\n\nE=Estimate. BAH estimates are for fiscal years ending March 2022 and March 23. SFIX estimates are for fiscal years ending July 2022 and July 2023. NM=Not Meaningful. NA=Not Available. *The annual EPS growth the company can sustain over the next 3-5 years.\nSource: FactSet\nAmedisys(AMED), a provider of home healthcare and hospice services, has a national footprint in a still-fragmented business.\n“There is going to be massive consolidation of the industry” predicts Dan Cole, a manager of the Columbia Small-Cap Growth fund. “Healthcare is moving to the home.”\nAmedisys stock is up more than tenfold in the past decade. But the shares, around $185, are off nearly 30% after the company recently cut 2021 financial guidance, citing Covid-related staffing and cost issues, mostly in acquired hospice operations. The 2021 earnings estimate is now $6.13 a share, down from nearly $7. The stock trades for 30 times projected 2021 profits. Cole says that the company remains capable of generating 10% annual gains in earnings per share.\nAmyris(AMRS) is a leader in synthetic biology. It fans say its opportunity is to supplant, in an eco-friendly way, a range of products now made from petrochemicals, animals, and plants.\nUsing genetically re-engineered yeast and sugar cane, Amyris produces such things as squalane, a high-end moisturizer formerly made from shark livers; vanillin, the flavoring for vanilla; and a no-calorie sweetener normally derived from plants. The stock trades around $13.\nBarron’s wrote favorably on the company in July. Amyris sees sales reaching $2 billion by 2025, up from an estimated $400 million this year, driven by its consumer brands.\n“The world needs clean chemistry, and Amyris is the point on the spear to create it,” says Randy Baron, a portfolio manager at Pinnacle Associates, which owns Amyris shares. He thinks they could hit $75 by the end of 2022.\nBooz Allen Hamilton Holding(BAH) is an important consultant to the Defense Department and other agencies. The U.S. government accounted for 97% of its revenue in its latest fiscal year. Booz Allen has built robust ties to the government over the years by providing an array of services, like cybersecurity. Its stock trades around $81, for a 1.8% yield.\n“It has built a strong, partnership-like culture and has a long record of steady growth,” says Josh Spencer, manager of the T. Rowe Price New Horizons fund. He sees Booz Allen as capable of generating 9% to 10% annual growth in revenue and yearly gains of 15% to 16% in earnings, in line with its historical performance. The stock is off 20% from its peak of $100, amid concerns about more restrained military spending. Spencer sees the pullback as a buying opportunity, with the stock valued at less than 20 times earnings.\nJ.B. Hunt Transport Services(JBHT) is a leader in intermodal freight, which involves the fuel-efficient movement of trucks over rail lines. It has been one of the most successful trucking companies. Its stock has risen 30-fold over the past 20 years, to a recent $173. “It has an incredible franchise,” says Henry Ellenbogen, chief investment officer at Durable Capital Partners and a member of the Barron’s Roundtable.\nJ.B. Hunt’s relationship with the Burlington Northern Santa Fe railroad gives it a strong position in intermodal freight, he notes. J.B. Hunt also has a growing business taking over the trucking operations of smaller companies. And it is involved in digital freight brokerage—matching truckers with shipping customers.\nEllenbogen says the stock is reasonable at 22 times estimated 2022 profits, given a mid-teens annual growth outlook for earnings.\nMarriott Vacations Worldwide(VAC) is one of the top companies in the timeshare industry. It has 700,000 owners, a resilient business model with significant revenue from fees, and more exposure than its peers to luxury properties in places including Hawaii and Orlando, Fla.\n“It has the best customer base, with the highest spending and an impeccable balance sheet,” says David Baron, a manager of the Baron Focused Growth fund. Marriott Vacations, whose shares recently were trading around $145, should reinstate its dividend later this year, he adds.\nThe shares, Baron argues, are cheap at a 11% free-cash-flow yield, based on 2022 estimates. He says that the stock, little changed since 2018, could produce 20% annual returns for shareholders in the coming years.\nSiteOne Landscape Supply(SITE) is the country’s top supplier of landscaping products, with ample opportunity to expand, given that it has just a 13% market share in a highly fragmented industry.\n\n“It’s growing organically and has lots of acquisition opportunities,” says Columbia’s Cole, who considers the company to be capable of 10% to 15% annual revenue growth.\nThe stock, around $197, has a rich valuation, trading for 43 times projected 2022 earnings of $4.54 a share.\nStaar Surgical(STAA) has developed an implantable lens to correct myopia (nearsightedness). That addresses a potentially huge market, given the rising global incidence of that vision problem. The company expects the lens, which has been available in Europe and Asia for at least five years, to be on the U.S. market in the fourth quarter, pending Food and Drug Administration approval.\n“It could do substantial volumes,’’ says Doug Brodie, a global manager at Baillie Gifford. “It’s early in a journey and is largely devoid of competition.”\nLenses for both eyes can be implanted in less than an hour, and they don’t involve the removal of the natural lenses. The wholesale cost in the U.S. could be around $1,000 per lens.\nAt a recent $138, Staar shares are richly valued at more than 20 times projected 2022 sales and 140 times estimated 2022 earnings. But the market opportunity is enormous: Some five billion people worldwide could have myopia by 2050.\nStitch Fix(SFIX) has developed a subscription service for clothing, shoes, and other accessories and boasts over four million customers.\n“This could be the Nordstrom of the future,” says Mario Cibelli, chief investment officer at Marathon Partners Equity Management, a Stitch Fix holder. “This a potentially huge market and nobody is addressing it in the same way.” Using a staff of 6,000 personal stylists and lots of data, Stitch Fix seeks to identify subscriber tastes to generate high satisfaction and limit returns on packages sent at intervals and determined by subscribers.\nIts shares, around $44, are down 60% from their level earlier in the year, on investors’ worries about potential churn and the business’s ultimate profitability.\nYet Cibelli sees revenue growth of 20%-plus annually, opportunities outside its current U.S. and U.K. markets, and a potentially very profitable business in two to three years.\nTrex(TREX) is the top producer of a high-end wood alternative for decks that comes from 95% recycled material, making it an eco-friendly housing play. The shares, at $105, trade for 43 times projected 2022 earnings.\nT. Rowe Price’s Spencer views Trex as worth the price, based on his view that it can generate sustainable annual revenue growth of 15% to 20%. Earnings are expected to climb by about 20% in 2022 and at a similar pace in the following years. “If you roll the clock forward three years, it doesn’t look as expensive,” he says.\nUpwork(UPWK), an online marketplace for freelance workers, is favored by Baillie Gifford’s Brodie, who says it offers a play on the greater acceptance of freelancers by businesses.\nThe shares, recently around $44, aren’t cheap. Upwork is valued at $5.7 billion, or more than 10 times this year’s projected sales of nearly $500 million. It operates at a slight loss.\nThe investment case is about rapid sales growth leading to ample earnings. Sales are expected to rise by 30%-plus this year and 25% for 2022.\n“Freelancers are more accepted by small to midsize business, but they’ve been frowned on by the HR departments at large businesses,” Brodie says. Upwork aims to change that perception by vetting its freelancers and by offering thousands of skill sets. “Upwork could become a trusted partner for an increasing number of enterprise-grade partners,” he says.","news_type":1},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":877683780,"gmtCreate":1637924524400,"gmtModify":1637924524523,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"😬😬","listText":"😬😬","text":"😬😬","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877683780","repostId":"1176160525","repostType":2,"repost":{"id":"1176160525","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637920107,"share":"https://www.laohu8.com/m/news/1176160525?lang=&edition=full","pubTime":"2021-11-26 17:48","market":"us","language":"zh","title":"盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮","url":"https://stock-news.laohu8.com/highlight/detail?id=1176160525","media":"老虎资讯综合","summary":"11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。\n\n美股区块链概念股盘前走低，Marathon Digital Holdings跌超8%，B","content":"<p>11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。</p>\n<p><img src=\"https://static.tigerbbs.com/5b49375b9c7bbdf2bc27f6abda87d2ef\" tg-width=\"385\" tg-height=\"191\" referrerpolicy=\"no-referrer\"></p>\n<p>美股区块链概念股盘前走低，<a href=\"https://laohu8.com/S/MARA\">Marathon Digital Holdings</a>跌超8%，<a href=\"https://laohu8.com/S/BTBT\">Bit Digital Inc</a>、<a href=\"https://laohu8.com/S/RIOT\">Riot Blockchain</a>、<a href=\"https://laohu8.com/S/CAN\">嘉楠科技</a>跌超7%，<a href=\"https://laohu8.com/S/SOS\">SOS Limited</a>跌超6%，<a href=\"https://laohu8.com/S/COIN\">Coinbase</a>跌超4%；</p>\n<p>美股油气板块盘前下挫，<a href=\"https://laohu8.com/S/CVE\">Cenovus能源</a>盘前跌8.88%，<a href=\"https://laohu8.com/S/BP\">英国石油</a>盘前跌6.5%，荷兰皇家壳牌盘前跌5.86%，<a href=\"https://laohu8.com/S/TTA.UK\">道达尔</a>、<a href=\"https://laohu8.com/S/XOM\">埃克森美孚</a>石油盘前跌5%，<a href=\"https://laohu8.com/S/CVX\">雪佛龙</a>盘前跌4.43%；</p>\n<p>美股抗疫概念股盘前走高，<a href=\"https://laohu8.com/S/AHPI\">联合保健产品</a>盘前涨超18%，Moderna盘前涨超10%，Ocugen盘前涨7.89%，<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>盘前涨6.9%，<a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯医药</a>盘前涨5.94%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>盘前涨超5%；</p>\n<p>美股大型科技股盘前普跌，<a href=\"https://laohu8.com/S/TSM\">台积电</a>、<a href=\"https://laohu8.com/S/NVDA\">英伟达</a>跌近3.5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌超3%，<a href=\"https://laohu8.com/S/MU\">美光科技</a>跌2.74%，<a href=\"https://laohu8.com/S/QCOM\">高通</a>、<a href=\"https://laohu8.com/S/FB\">Meta Platforms</a>跌超2%，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>、<a href=\"https://laohu8.com/S/INTC\">英特尔</a>跌1.9%，<a href=\"https://laohu8.com/S/CSCO\">思科</a>跌1.4%，<a href=\"https://laohu8.com/S/MSFT\">微软</a>跌1.04%；</p>\n<p>美股邮轮、航空股盘前集体重挫，<a href=\"https://laohu8.com/S/CCL\">嘉年华邮轮</a>跌超10%，<a href=\"https://laohu8.com/S/NCLH\">挪威邮轮</a>跌超7%；<a href=\"https://laohu8.com/S/DAL\">达美航空</a>、<a href=\"https://laohu8.com/S/UAL\">联合大陆航空</a>跌超7%，美国航空跌超5%；</p>\n<p>中概股盘前多数下跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>一度跌超8%；<a href=\"https://laohu8.com/S/KC\">金山云</a>跌6.73%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>跌6.36%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌5.6%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>、<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>跌超5%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌超4%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌近4.7%；</p>\n<p><a href=\"https://laohu8.com/S/FFIE\">法拉第未来</a>盘前跌5.5%，公司收到美国退市警告，要求60天内提交合规计划；</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a>盘前逆市拉升，涨超11%，ARK基金持续买入Zoom Video的股票。</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮 </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前异动：变异毒株来势汹汹！美股再度引发抛售狂潮 \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-11-26 17:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。</p>\n<p><img src=\"https://static.tigerbbs.com/5b49375b9c7bbdf2bc27f6abda87d2ef\" tg-width=\"385\" tg-height=\"191\" referrerpolicy=\"no-referrer\"></p>\n<p>美股区块链概念股盘前走低，<a href=\"https://laohu8.com/S/MARA\">Marathon Digital Holdings</a>跌超8%，<a href=\"https://laohu8.com/S/BTBT\">Bit Digital Inc</a>、<a href=\"https://laohu8.com/S/RIOT\">Riot Blockchain</a>、<a href=\"https://laohu8.com/S/CAN\">嘉楠科技</a>跌超7%，<a href=\"https://laohu8.com/S/SOS\">SOS Limited</a>跌超6%，<a href=\"https://laohu8.com/S/COIN\">Coinbase</a>跌超4%；</p>\n<p>美股油气板块盘前下挫，<a href=\"https://laohu8.com/S/CVE\">Cenovus能源</a>盘前跌8.88%，<a href=\"https://laohu8.com/S/BP\">英国石油</a>盘前跌6.5%，荷兰皇家壳牌盘前跌5.86%，<a href=\"https://laohu8.com/S/TTA.UK\">道达尔</a>、<a href=\"https://laohu8.com/S/XOM\">埃克森美孚</a>石油盘前跌5%，<a href=\"https://laohu8.com/S/CVX\">雪佛龙</a>盘前跌4.43%；</p>\n<p>美股抗疫概念股盘前走高，<a href=\"https://laohu8.com/S/AHPI\">联合保健产品</a>盘前涨超18%，Moderna盘前涨超10%，Ocugen盘前涨7.89%，<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>盘前涨6.9%，<a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯医药</a>盘前涨5.94%，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>盘前涨超5%；</p>\n<p>美股大型科技股盘前普跌，<a href=\"https://laohu8.com/S/TSM\">台积电</a>、<a href=\"https://laohu8.com/S/NVDA\">英伟达</a>跌近3.5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌超3%，<a href=\"https://laohu8.com/S/MU\">美光科技</a>跌2.74%，<a href=\"https://laohu8.com/S/QCOM\">高通</a>、<a href=\"https://laohu8.com/S/FB\">Meta Platforms</a>跌超2%，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>、<a href=\"https://laohu8.com/S/INTC\">英特尔</a>跌1.9%，<a href=\"https://laohu8.com/S/CSCO\">思科</a>跌1.4%，<a href=\"https://laohu8.com/S/MSFT\">微软</a>跌1.04%；</p>\n<p>美股邮轮、航空股盘前集体重挫，<a href=\"https://laohu8.com/S/CCL\">嘉年华邮轮</a>跌超10%，<a href=\"https://laohu8.com/S/NCLH\">挪威邮轮</a>跌超7%；<a href=\"https://laohu8.com/S/DAL\">达美航空</a>、<a href=\"https://laohu8.com/S/UAL\">联合大陆航空</a>跌超7%，美国航空跌超5%；</p>\n<p>中概股盘前多数下跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>一度跌超8%；<a href=\"https://laohu8.com/S/KC\">金山云</a>跌6.73%，<a href=\"https://laohu8.com/S/TAL\">好未来</a>跌6.36%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌5.6%，<a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>、<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、<a href=\"https://laohu8.com/S/BEKE\">贝壳</a>跌超5%，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌超4%，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌近4.7%；</p>\n<p><a href=\"https://laohu8.com/S/FFIE\">法拉第未来</a>盘前跌5.5%，公司收到美国退市警告，要求60天内提交合规计划；</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a>盘前逆市拉升，涨超11%，ARK基金持续买入Zoom Video的股票。</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176160525","content_text":"11月26日，美股股指期货全线大跌，道指期货跌2.23%，纳指期货跌1.26%，标普500指数跌1.84%。\n\n美股区块链概念股盘前走低，Marathon Digital Holdings跌超8%，Bit Digital Inc、Riot Blockchain、嘉楠科技跌超7%，SOS Limited跌超6%，Coinbase跌超4%；\n美股油气板块盘前下挫，Cenovus能源盘前跌8.88%，英国石油盘前跌6.5%，荷兰皇家壳牌盘前跌5.86%，道达尔、埃克森美孚石油盘前跌5%，雪佛龙盘前跌4.43%；\n美股抗疫概念股盘前走高，联合保健产品盘前涨超18%，Moderna盘前涨超10%，Ocugen盘前涨7.89%，BioNTech SE盘前涨6.9%，诺瓦瓦克斯医药盘前涨5.94%，辉瑞盘前涨超5%；\n美股大型科技股盘前普跌，台积电、英伟达跌近3.5%，特斯拉跌超3%，美光科技跌2.74%，高通、Meta Platforms跌超2%，苹果、英特尔跌1.9%，思科跌1.4%，微软跌1.04%；\n美股邮轮、航空股盘前集体重挫，嘉年华邮轮跌超10%，挪威邮轮跌超7%；达美航空、联合大陆航空跌超7%，美国航空跌超5%；\n中概股盘前多数下跌，滴滴一度跌超8%；金山云跌6.73%，好未来跌6.36%，爱奇艺跌5.6%，小鹏汽车、蔚来、贝壳跌超5%，阿里巴巴跌超4%，理想汽车跌近4.7%；\n法拉第未来盘前跌5.5%，公司收到美国退市警告，要求60天内提交合规计划；\nZoom盘前逆市拉升，涨超11%，ARK基金持续买入Zoom Video的股票。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843487130,"gmtCreate":1635850675709,"gmtModify":1635850675814,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843487130","repostId":"1193558756","repostType":4,"repost":{"id":"1193558756","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635850584,"share":"https://www.laohu8.com/m/news/1193558756?lang=&edition=full","pubTime":"2021-11-02 18:56","market":"us","language":"en","title":"Pfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1193558756","media":"Tiger Newspress","summary":"Pfizer Inc on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 bi","content":"<p>Pfizer Inc&nbsp;on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.</p>\n<p>The company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech .</p>\n<p>Driven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.</p>\n<p>The company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.</p>\n<p>Pfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year.</p>\n<p>Its&nbsp;shares&nbsp;rose&nbsp;over 2% in premarket trading.<img src=\"https://static.tigerbbs.com/df663bc64292fce6036a0c102eb67471\" tg-width=\"770\" tg-height=\"566\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer rose over 2% in premarket trading as it raised COVID-19 vaccine sales forecast to $36 bln for 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 18:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc&nbsp;on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.</p>\n<p>The company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech .</p>\n<p>Driven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.</p>\n<p>The company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.</p>\n<p>Pfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year.</p>\n<p>Its&nbsp;shares&nbsp;rose&nbsp;over 2% in premarket trading.<img src=\"https://static.tigerbbs.com/df663bc64292fce6036a0c102eb67471\" tg-width=\"770\" tg-height=\"566\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193558756","content_text":"Pfizer Inc on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.\nThe company had in July forecast sales of $33.5 billion from the vaccine it sells with BioNTech .\nDriven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selling products in the company's roughly 172-year history.\nThe company, which was well known for drugs such as Xanax and Viagra, equally splits expenses and profit with its German partner.\nPfizer expects to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it expects to make this year.\nIts shares rose over 2% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":908,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":882253545,"gmtCreate":1631698884587,"gmtModify":1631889843283,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"okay","listText":"okay","text":"okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882253545","repostId":"1108272392","repostType":4,"repost":{"id":"1108272392","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631693345,"share":"https://www.laohu8.com/m/news/1108272392?lang=&edition=full","pubTime":"2021-09-15 16:09","market":"us","language":"en","title":"Apple shares rose 0.4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1108272392","media":"Tiger Newspress","summary":"Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the new iPhone 13 in","content":"<p>Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the&nbsp;new iPhone 13 in all of its versions were unveiled. The stock closed down 0.96% at $148.12.</p>\n<p><img src=\"https://static.tigerbbs.com/43a1bc16e540f70c96b045c162ee647d\" tg-width=\"850\" tg-height=\"638\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple shares rose 0.4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple shares rose 0.4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 16:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the&nbsp;new iPhone 13 in all of its versions were unveiled. The stock closed down 0.96% at $148.12.</p>\n<p><img src=\"https://static.tigerbbs.com/43a1bc16e540f70c96b045c162ee647d\" tg-width=\"850\" tg-height=\"638\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108272392","content_text":"Apple shares rose 0.4% in premarket trading.Apple held an event yesterday where the new iPhone 13 in all of its versions were unveiled. The stock closed down 0.96% at $148.12.","news_type":1},"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805414977,"gmtCreate":1627898548599,"gmtModify":1631892364956,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"great","listText":"great","text":"great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805414977","repostId":"1185600084","repostType":4,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":805415331,"gmtCreate":1627898476723,"gmtModify":1631892364967,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"🤔","listText":"🤔","text":"🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/805415331","repostId":"1131923658","repostType":4,"repost":{"id":"1131923658","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627898076,"share":"https://www.laohu8.com/m/news/1131923658?lang=&edition=full","pubTime":"2021-08-02 17:54","market":"us","language":"en","title":"Can Tesla's stock price return to the upward channel?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131923658","media":"Tiger Newspress","summary":"Tesla released Q2 earnings and revenues last week that beat analysts' expectations.\n\"In the second q","content":"<p>Tesla released Q2 earnings and revenues last week that beat analysts' expectations.</p>\n<p>\"In the second quarter of 2021, we broke new and notable records,\" said Tesla in the company's second-quarter update. \"We produced and delivered over 200,000 vehicles, achieved an operating margin of 11% and exceeded [$1 billion] of GAAP net income for the first time in our history.\"</p>\n<p>Here's a closer look at the quarter, captured by five must-see takeaways from the report.</p>\n<p><b>1. Revenue hit $12 billion</b></p>\n<p>Helped by a 121% year-over-year increase in vehicle deliveries, Tesla's revenue surged 98% year over year to approximately $12 billion. This crushed analysts' average forecast for revenue of $11.3 billion.</p>\n<p><b>2. Profits skyrocketed</b></p>\n<p>Of course, with revenue like this, it wasn't surprising to see profits soar. Net income increased from $104 million in the year-ago period to $1.14 billion. Non-GAAP (adjusted) net income increased 258% year over year to $1.6 billion. This translated to non-GAAP earnings per share of $1.45 -- far ahead of a consensus analyst estimate of $0.98.</p>\n<p>The outsized growth in Tesla's profits demonstrates the scalability of the company's business model.</p>\n<p><b>3. Free cash flow remains healthy</b></p>\n<p>Tesla once again generated positive free cash flow, or cash flow from operations less capital expenditures. Free cash flow for the period increased from $418 million in the year-ago period to $619 million.</p>\n<p>Total cash on hand fell from $17.1 billion in the first quarter of 2021 to $16.2 billion but this was primarily due to $1.6 billion in net debt and finance lease repayments.</p>\n<p><b>4. Vehicle demand is robust</b></p>\n<p>Tesla once again said demand for its vehicles achieved record levels. Indeed, demand is so robust that the company is supply constrained. \"Global demand continues to be robust, and we are producing at the limits of available parts supply,\" Tesla explained.</p>\n<p><b>5. There's more sharp growth to come</b></p>\n<p>Importantly, Tesla remains optimistic about its growth trajectory. The company says it continues to expect to grow its total deliveries more than 50% year over year this year. This implies 2021 total deliveries of more than 750,000. So far, Tesla has delivered more than 386,000 vehicles this year.</p>\n<p>\"The rate of growth will depend on our equipment capacity, operational efficiency, and the capacity and stability of the supply chain,\" Tesla noted.</p>\n<h4>Four Challenges to Tesla’s Growth</h4>\n<p>However,investors are concerned with several factors that may slow Tesla's feverish share price growth soon.</p>\n<p><b>High Valuation</b></p>\n<p>Wall Street is an efficient market, discounting good news and bad news on listed companies. As a result, shares are run-up ahead of good news and sold-off ahead of bad news. Sometimes, Mr. Market—to use Benjamin Graham's terminology—is too optimistic, sending the shares of listed companies well above their fundamental or intrinsic value. Other times, Mr. Market is too pessimistic, sending shares of listed companies well below their intrinsic value.</p>\n<p>Tesla's shares are overvalued by many standards. TipRanks, for instance, estimates Tesla's 12-month-trailing return on equity to be a modest 12.41%, while estimates put Tesla's intrinsic value at $160.11, well below its current price level.</p>\n<p><b>Competition from Colonizers</b></p>\n<p>Once, Tesla had little competition, as the electric vehicle (EV) market it pioneered had little competition from traditional automakers. However, that's no longer the case, as General Motors, Ford, Volkswagen, and Toyota are invading the electric market.</p>\n<p>These \"colonizers\" of the EV market have the manufacturing experience, expertise, and distribution networks to scale up EV production and cross the \"tipping point\" of bringing EVs to the masses. Meanwhile, the entry of new competitors into the EV market could unleash price competition that will erode Tesla's revenue growth and profit margins. That's something Wall Street is watching closely in quarterly financial statements.</p>\n<p><b>Bitcoin Exposure</b></p>\n<p>Tesla's CEO Elon Musk has an affinity for bitcoin. That's why he has been investing some of the company's cash in digital currency. As of the end of March, Tesla's $1.5 billion investment was worth $2.48 billion, based on the surge in bitcoin in the first quarter. However, that has its risks, too, given bitcoin's volatility.</p>\n<p>Adding to bitcoin's volatility are accounting rules that treat the digital currency as an indefinite-lived intangible asset. Thus, it is subject to impairment losses if its fair value decreases below the carrying value during the assessed reporting period. Companies cannot recover impairment losses for any subsequent increase in fair value until the asset's sale. Tesla reported bitcoin-related impairments of $23 million in Q2 as the price of digital currency dived.</p>\n<p><b>Rising Material Costs</b></p>\n<p>Together with traditional automobile makers, Tesla faces a severe material shortage due to supply chain disruptions during the COVID-19 pandemic, which is expected to slow down the pace of its feverish growth.</p>\n<p>\"While we're making cars at full speed, the global chip shortage situation remains quite serious,\" Musk told investors. \"For the rest of this year, our growth rates will be determined by the slowest part in our supply chain,\" adding that there are a wide range of chips that will serve as that brake on growth.</p>\n<h4>Mixed reviews from Wall Street</h4>\n<p>Needham analyst Rajvindra Gill said Tesla shares are already priced to perfection, which could explain the stock’s weakness on Tuesday.</p>\n<p>“Tesla's ‘priced to perfection’ valuation is hard for us to justify, even with more positive recent Results,” Gill wrote.</p>\n<p>Morgan Stanley analyst Adam Jonas said the quarter likely didn’t change the narrative for bulls or bears, and Tesla is still not a value stock priced at an enterprise multiple of 70x.</p>\n<p>“Tesla is not only among the fastest growing auto companies in the world, it is also one of the most profitable,” Jonas wrote.</p>\n<p>Wells Fargo analyst Colin Langan said auto gross margins were impressive, but they may not last.</p>\n<p>“We see auto margins moderating in Q3/Q4 due to rising raw mat costs and mix dilution as the lower priced Model Y SR launches in China,” Langran wrote.</p>\n<p>John Murphy with B. of A. Securities struck a more cautious tone. Despite the beat, \"competition is fierce and heating up,\" he said. \"(Tesla's) operating environment is shifting from that of a vacuum to an increasingly crowded space.\"</p>\n<p>The quarterly beat was \"very much helped by positive pricing dynamics and good execution,\" and Murphy raised his price target on the stock to $800 from $750, which represents an upside around 26% from Tuesday's prices. He kept B. of A.'s neutral rating on the stock.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Tesla's stock price return to the upward channel?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Tesla's stock price return to the upward channel?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-02 17:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tesla released Q2 earnings and revenues last week that beat analysts' expectations.</p>\n<p>\"In the second quarter of 2021, we broke new and notable records,\" said Tesla in the company's second-quarter update. \"We produced and delivered over 200,000 vehicles, achieved an operating margin of 11% and exceeded [$1 billion] of GAAP net income for the first time in our history.\"</p>\n<p>Here's a closer look at the quarter, captured by five must-see takeaways from the report.</p>\n<p><b>1. Revenue hit $12 billion</b></p>\n<p>Helped by a 121% year-over-year increase in vehicle deliveries, Tesla's revenue surged 98% year over year to approximately $12 billion. This crushed analysts' average forecast for revenue of $11.3 billion.</p>\n<p><b>2. Profits skyrocketed</b></p>\n<p>Of course, with revenue like this, it wasn't surprising to see profits soar. Net income increased from $104 million in the year-ago period to $1.14 billion. Non-GAAP (adjusted) net income increased 258% year over year to $1.6 billion. This translated to non-GAAP earnings per share of $1.45 -- far ahead of a consensus analyst estimate of $0.98.</p>\n<p>The outsized growth in Tesla's profits demonstrates the scalability of the company's business model.</p>\n<p><b>3. Free cash flow remains healthy</b></p>\n<p>Tesla once again generated positive free cash flow, or cash flow from operations less capital expenditures. Free cash flow for the period increased from $418 million in the year-ago period to $619 million.</p>\n<p>Total cash on hand fell from $17.1 billion in the first quarter of 2021 to $16.2 billion but this was primarily due to $1.6 billion in net debt and finance lease repayments.</p>\n<p><b>4. Vehicle demand is robust</b></p>\n<p>Tesla once again said demand for its vehicles achieved record levels. Indeed, demand is so robust that the company is supply constrained. \"Global demand continues to be robust, and we are producing at the limits of available parts supply,\" Tesla explained.</p>\n<p><b>5. There's more sharp growth to come</b></p>\n<p>Importantly, Tesla remains optimistic about its growth trajectory. The company says it continues to expect to grow its total deliveries more than 50% year over year this year. This implies 2021 total deliveries of more than 750,000. So far, Tesla has delivered more than 386,000 vehicles this year.</p>\n<p>\"The rate of growth will depend on our equipment capacity, operational efficiency, and the capacity and stability of the supply chain,\" Tesla noted.</p>\n<h4>Four Challenges to Tesla’s Growth</h4>\n<p>However,investors are concerned with several factors that may slow Tesla's feverish share price growth soon.</p>\n<p><b>High Valuation</b></p>\n<p>Wall Street is an efficient market, discounting good news and bad news on listed companies. As a result, shares are run-up ahead of good news and sold-off ahead of bad news. Sometimes, Mr. Market—to use Benjamin Graham's terminology—is too optimistic, sending the shares of listed companies well above their fundamental or intrinsic value. Other times, Mr. Market is too pessimistic, sending shares of listed companies well below their intrinsic value.</p>\n<p>Tesla's shares are overvalued by many standards. TipRanks, for instance, estimates Tesla's 12-month-trailing return on equity to be a modest 12.41%, while estimates put Tesla's intrinsic value at $160.11, well below its current price level.</p>\n<p><b>Competition from Colonizers</b></p>\n<p>Once, Tesla had little competition, as the electric vehicle (EV) market it pioneered had little competition from traditional automakers. However, that's no longer the case, as General Motors, Ford, Volkswagen, and Toyota are invading the electric market.</p>\n<p>These \"colonizers\" of the EV market have the manufacturing experience, expertise, and distribution networks to scale up EV production and cross the \"tipping point\" of bringing EVs to the masses. Meanwhile, the entry of new competitors into the EV market could unleash price competition that will erode Tesla's revenue growth and profit margins. That's something Wall Street is watching closely in quarterly financial statements.</p>\n<p><b>Bitcoin Exposure</b></p>\n<p>Tesla's CEO Elon Musk has an affinity for bitcoin. That's why he has been investing some of the company's cash in digital currency. As of the end of March, Tesla's $1.5 billion investment was worth $2.48 billion, based on the surge in bitcoin in the first quarter. However, that has its risks, too, given bitcoin's volatility.</p>\n<p>Adding to bitcoin's volatility are accounting rules that treat the digital currency as an indefinite-lived intangible asset. Thus, it is subject to impairment losses if its fair value decreases below the carrying value during the assessed reporting period. Companies cannot recover impairment losses for any subsequent increase in fair value until the asset's sale. Tesla reported bitcoin-related impairments of $23 million in Q2 as the price of digital currency dived.</p>\n<p><b>Rising Material Costs</b></p>\n<p>Together with traditional automobile makers, Tesla faces a severe material shortage due to supply chain disruptions during the COVID-19 pandemic, which is expected to slow down the pace of its feverish growth.</p>\n<p>\"While we're making cars at full speed, the global chip shortage situation remains quite serious,\" Musk told investors. \"For the rest of this year, our growth rates will be determined by the slowest part in our supply chain,\" adding that there are a wide range of chips that will serve as that brake on growth.</p>\n<h4>Mixed reviews from Wall Street</h4>\n<p>Needham analyst Rajvindra Gill said Tesla shares are already priced to perfection, which could explain the stock’s weakness on Tuesday.</p>\n<p>“Tesla's ‘priced to perfection’ valuation is hard for us to justify, even with more positive recent Results,” Gill wrote.</p>\n<p>Morgan Stanley analyst Adam Jonas said the quarter likely didn’t change the narrative for bulls or bears, and Tesla is still not a value stock priced at an enterprise multiple of 70x.</p>\n<p>“Tesla is not only among the fastest growing auto companies in the world, it is also one of the most profitable,” Jonas wrote.</p>\n<p>Wells Fargo analyst Colin Langan said auto gross margins were impressive, but they may not last.</p>\n<p>“We see auto margins moderating in Q3/Q4 due to rising raw mat costs and mix dilution as the lower priced Model Y SR launches in China,” Langran wrote.</p>\n<p>John Murphy with B. of A. Securities struck a more cautious tone. Despite the beat, \"competition is fierce and heating up,\" he said. \"(Tesla's) operating environment is shifting from that of a vacuum to an increasingly crowded space.\"</p>\n<p>The quarterly beat was \"very much helped by positive pricing dynamics and good execution,\" and Murphy raised his price target on the stock to $800 from $750, which represents an upside around 26% from Tuesday's prices. He kept B. of A.'s neutral rating on the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131923658","content_text":"Tesla released Q2 earnings and revenues last week that beat analysts' expectations.\n\"In the second quarter of 2021, we broke new and notable records,\" said Tesla in the company's second-quarter update. \"We produced and delivered over 200,000 vehicles, achieved an operating margin of 11% and exceeded [$1 billion] of GAAP net income for the first time in our history.\"\nHere's a closer look at the quarter, captured by five must-see takeaways from the report.\n1. Revenue hit $12 billion\nHelped by a 121% year-over-year increase in vehicle deliveries, Tesla's revenue surged 98% year over year to approximately $12 billion. This crushed analysts' average forecast for revenue of $11.3 billion.\n2. Profits skyrocketed\nOf course, with revenue like this, it wasn't surprising to see profits soar. Net income increased from $104 million in the year-ago period to $1.14 billion. Non-GAAP (adjusted) net income increased 258% year over year to $1.6 billion. This translated to non-GAAP earnings per share of $1.45 -- far ahead of a consensus analyst estimate of $0.98.\nThe outsized growth in Tesla's profits demonstrates the scalability of the company's business model.\n3. Free cash flow remains healthy\nTesla once again generated positive free cash flow, or cash flow from operations less capital expenditures. Free cash flow for the period increased from $418 million in the year-ago period to $619 million.\nTotal cash on hand fell from $17.1 billion in the first quarter of 2021 to $16.2 billion but this was primarily due to $1.6 billion in net debt and finance lease repayments.\n4. Vehicle demand is robust\nTesla once again said demand for its vehicles achieved record levels. Indeed, demand is so robust that the company is supply constrained. \"Global demand continues to be robust, and we are producing at the limits of available parts supply,\" Tesla explained.\n5. There's more sharp growth to come\nImportantly, Tesla remains optimistic about its growth trajectory. The company says it continues to expect to grow its total deliveries more than 50% year over year this year. This implies 2021 total deliveries of more than 750,000. So far, Tesla has delivered more than 386,000 vehicles this year.\n\"The rate of growth will depend on our equipment capacity, operational efficiency, and the capacity and stability of the supply chain,\" Tesla noted.\nFour Challenges to Tesla’s Growth\nHowever,investors are concerned with several factors that may slow Tesla's feverish share price growth soon.\nHigh Valuation\nWall Street is an efficient market, discounting good news and bad news on listed companies. As a result, shares are run-up ahead of good news and sold-off ahead of bad news. Sometimes, Mr. Market—to use Benjamin Graham's terminology—is too optimistic, sending the shares of listed companies well above their fundamental or intrinsic value. Other times, Mr. Market is too pessimistic, sending shares of listed companies well below their intrinsic value.\nTesla's shares are overvalued by many standards. TipRanks, for instance, estimates Tesla's 12-month-trailing return on equity to be a modest 12.41%, while estimates put Tesla's intrinsic value at $160.11, well below its current price level.\nCompetition from Colonizers\nOnce, Tesla had little competition, as the electric vehicle (EV) market it pioneered had little competition from traditional automakers. However, that's no longer the case, as General Motors, Ford, Volkswagen, and Toyota are invading the electric market.\nThese \"colonizers\" of the EV market have the manufacturing experience, expertise, and distribution networks to scale up EV production and cross the \"tipping point\" of bringing EVs to the masses. Meanwhile, the entry of new competitors into the EV market could unleash price competition that will erode Tesla's revenue growth and profit margins. That's something Wall Street is watching closely in quarterly financial statements.\nBitcoin Exposure\nTesla's CEO Elon Musk has an affinity for bitcoin. That's why he has been investing some of the company's cash in digital currency. As of the end of March, Tesla's $1.5 billion investment was worth $2.48 billion, based on the surge in bitcoin in the first quarter. However, that has its risks, too, given bitcoin's volatility.\nAdding to bitcoin's volatility are accounting rules that treat the digital currency as an indefinite-lived intangible asset. Thus, it is subject to impairment losses if its fair value decreases below the carrying value during the assessed reporting period. Companies cannot recover impairment losses for any subsequent increase in fair value until the asset's sale. Tesla reported bitcoin-related impairments of $23 million in Q2 as the price of digital currency dived.\nRising Material Costs\nTogether with traditional automobile makers, Tesla faces a severe material shortage due to supply chain disruptions during the COVID-19 pandemic, which is expected to slow down the pace of its feverish growth.\n\"While we're making cars at full speed, the global chip shortage situation remains quite serious,\" Musk told investors. \"For the rest of this year, our growth rates will be determined by the slowest part in our supply chain,\" adding that there are a wide range of chips that will serve as that brake on growth.\nMixed reviews from Wall Street\nNeedham analyst Rajvindra Gill said Tesla shares are already priced to perfection, which could explain the stock’s weakness on Tuesday.\n“Tesla's ‘priced to perfection’ valuation is hard for us to justify, even with more positive recent Results,” Gill wrote.\nMorgan Stanley analyst Adam Jonas said the quarter likely didn’t change the narrative for bulls or bears, and Tesla is still not a value stock priced at an enterprise multiple of 70x.\n“Tesla is not only among the fastest growing auto companies in the world, it is also one of the most profitable,” Jonas wrote.\nWells Fargo analyst Colin Langan said auto gross margins were impressive, but they may not last.\n“We see auto margins moderating in Q3/Q4 due to rising raw mat costs and mix dilution as the lower priced Model Y SR launches in China,” Langran wrote.\nJohn Murphy with B. of A. Securities struck a more cautious tone. Despite the beat, \"competition is fierce and heating up,\" he said. \"(Tesla's) operating environment is shifting from that of a vacuum to an increasingly crowded space.\"\nThe quarterly beat was \"very much helped by positive pricing dynamics and good execution,\" and Murphy raised his price target on the stock to $800 from $750, which represents an upside around 26% from Tuesday's prices. He kept B. of A.'s neutral rating on the stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":846918666,"gmtCreate":1636039126666,"gmtModify":1636040133341,"author":{"id":"4088479336191950","authorId":"4088479336191950","name":"Tj_","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088479336191950","authorIdStr":"4088479336191950"},"themes":[],"htmlText":"Earn &amp; redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&amp;Page=Me&amp;lang=en_US&amp;skin=1&amp;platform=ios&amp;invite=OX9U7S&amp;share=WhatsAPP#/","listText":"Earn &amp; redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&amp;Page=Me&amp;lang=en_US&amp;skin=1&amp;platform=ios&amp;invite=OX9U7S&amp;share=WhatsAPP#/","text":"Earn & redeem in-game rewards including Stock Vouchers, Free Shares, Commission-Free Trades, and more! * Free game ends soon...Click to start now! https://www.tigerbrokers.com.sg/activity/market/2021/halloween/*OX9U7S-index.html?feature=Banner&Page=Me&lang=en_US&skin=1&platform=ios&invite=OX9U7S&share=WhatsAPP#/","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846918666","isVote":1,"tweetType":1,"viewCount":1177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}